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ABSTRACT 
 
Background: Non-disclosure of HIV positive status to a partner threatens to reverse 
gains made in prevention of mother-to-child transmission (PMTCT) in resource 
limited settings. Determining the association between non-disclosure and infant HIV 
acquisition is important to justify focussing on disclosure as a strategy in PMTCT 
programmes. 
Objective: To determine the association between non-disclosure of HIV positive 
status to a partner and mother-to-child transmission (MTCT). 
Methods: Using a matched case-control design, we compared 34 HIV positive 
infants to 146 HIV negative infants and evaluated whether the mothers had disclosed 
their HIV status to their partner. 
Results: Non-disclosure was more frequent among cases (overall, 16.7%; cases, 
52.8%; controls 7.6%), p<0.001 and significantly associated with MTCT (aOR 8.9 
(3.0-26.3); p<0.0001), with male partner involvement partially mediating the effect of 
non-disclosure on MTCT. 
Conclusions: There is a need for PMTCT programmes to focus on strategies to 
improve male partner involvement and partner disclosure without compromising the 
woman’s safety. 
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Non-disclosure; MTCT; vertical transmission; male partner involvement; matched 
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CHAPTER 1 
 
ORIENTATION TO THE STUDY 
 
 
1.1 INTRODUCTION 
 
“The world has a unique opportunity for an AIDS-free generation. 
We owe this to our children”. 
 
Michel Sidibé, UNAIDS Executive Director 
 
A heartrending outcome of HIV infection in women is the ability of transmitting the virus 
from the mother to the child.  The above statement by the United Nations Program on 
HIV/AIDS (UNAIDS) Director is a reminder, and a call for everyone to take advantage of 
the opportunity to right an injustice that nature bequeathed upon innocent children. 
 
Although the global community has committed itself to accelerate progress in the 
prevention of mother-to-child HIV transmission (PMTCT), and a lot of achievements 
made with a 58 percent reduction in the number of new HIV infections among children 
between 2002 and 2013 globally, cases of children being infected by their mothers still 
abound. In 2013 alone, more than 240,000 children were infected with HIV, an 
equivalent of 700 new infections every day (UNAIDS 2014:8). The high incidence of HIV 
among children, especially in sub-Saharan Africa has contributed to the increased infant 
and child mortality, and is credited with the reversed gains realised in child health and 
survival in the last decade (United Nations Children’s Fund 2008:7), clearly 
demonstrating the need and importance of eliminating mother-to-child HIV transmission 
(EMTCT) (United Nations Program on HIV/AIDS 2013:28). 
 
Antenatal HIV testing and counselling and partner disclosure are pillars of PMTCT. 
These two strategies empower HIV positive women to make early decisions regarding 
their health and that of their baby, which promotes adherence to PMTCT interventions 
(Baggaley, Hensen, Ajose, Grabbe, Wong, Schilsky, Lo, Lule, Granich & Hargreaves 
2012:653). Whereas the uptake of antenatal HIV testing and counselling has been high, 
partner disclosure has remained low, raising concern about the possibility of non-
disclosure of positive HIV status by pregnant women to their partners being a hindrance 
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to EMTCT (Villar-Loubet, Bruscantini, Shikwane, Weiss, Peltzer & Jones 2013:264). 
The concern is validated by the adoption of a “combination HIV prevention strategy” by 
the World Health Organization (WHO) due to synergistic roles of biomedical, 
behavioural, structural and supportive risk factors in MTCT (World Health Organization 
2013:84). 
 
While a lot of studies have focussed on determining the association between clinical risk 
factors and MTCT, evaluation of the impact of behavioural risk factors particularly non-
disclosure of positive HIV status to a partner on MTCT has not been extensively 
investigated.  The study therefore determined, using a case-control study, the nature of 
association between non-disclosure of positive HIV status to a partner and MTCT. 
 
1.2 BACKGROUND INFORMATION ABOUT THE RESEARCH PROBLEM 
 
1.2.1 Source of the research problem  
 
Working as an improvement advisor in maternal, neonatal and child health led to the 
conceptualisation of this study. It was noted that in addition to many HIV positive 
pregnant women in rural health facilities in Kenya being unaware of their partner’s HIV 
status, the majority of them were also not being accompanied by their partners during 
clinic visits as a show of support. In 2012, less than 4.5% of HIV positive pregnant 
women in Kenya were accompanied by their partners to the clinic, and less than 3% 
were unaware of their partner’s HIV status (National AIDS Control Council 2014:14, 21). 
The two observations begged the questions of whether a HIV positive woman would 
willingly disclose her status to her partner despite being unaware of his status. Would 
the poor show of support by the male partners be explained by non-disclosure? And 
since in most rural African settings men are still the primary decision makers and as 
such determine the health seeking behaviours of their women and children, would the 
non- disclosure and lack of male partner support impact on MTCT?  
 
Preliminary literature searches identified an information gap. While rates, barriers and 
effects of disclosure have been extensively studied, to my knowledge, no study in 
Kenya, and very few studies globally have directly evaluated the association between 
non-disclosure of HIV positive status to a partner and MTCT, and whether the 
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association is indirectly mediated through lack of male partner support. Therefore the 
necessity and importance of this study is evident. 
 
1.2.2 Background to the research problem 
 
MTCT is responsible for more than 90% of HIV infections in children (The Independent 
Expert Panel 2010:3), and can occur during pregnancy, childbirth, or through breast 
feeding (Ahmad 2011:982). Without any intervention the risk of transmission is 15-30% 
in non-breastfeeding populations and 20-45% in breastfeeding populations (World 
Health Organization 2013:84). However, the risk of transmission can be reduced to less 
than 1% through PMTCT interventions as demonstrated in high income countries 
(Frange & Blanche 2014:692; Townsend, Cortina-Borja, Peckham, De Ruiter, Lyall & 
Tookey 2008:978). Unfortunately, many countries in sub-Saharan Africa still experience 
high MTCT rates. For example, the MTCT rate in Kenya stands at 16% (Kenya National 
AIDS and STI Control Programme 2013:17).  
 
In sub-Saharan Africa, lack of partner support for HIV positive women attending 
antenatal clinic is one of the obstacles in the elimination of MTCT (Aluisio, Richardson, 
Bosire, John-Stewart, Mbori-Ngacha & Farquhar 2011:80). Male partner support is 
crucial as it enhances optimal uptake of PMTCT services (Njunga 2008:68; Villar-
Loubet et al 2013:266). However, for support to be offered, disclosure must happen 
(Bachanas, Medley, Pals, Kidder, Antelman, Benech, DeLuca, Nuwagaba-Biribonwoha, 
Muhenje, Cherutich, Kariuki, Katuta & Bukuku, for PWP study group 2013:429). 
 
The benefits of partner disclosure are well known. In addition to the public health 
benefits of expanded awareness of risk that may lead to decreased sexual risk-taking 
and ultimately decreased transmission of HIV, there are potential benefits on MTCT. 
Overall, males who take part in healthcare processes (antenatal PMTCT or HIV testing) 
have more knowledge of, and involvement in, their families’ health and subsequently 
better support women to prevent infant HIV infection (Aluisio et al 2011:81). Specifically, 
disclosure increases the uptake of antiretroviral drugs for PMTCT, including early 
initiation of HAART and enhanced uptake of infant prophylaxis (Aluisio et al 2011:80; 
Jasseron, Mandelbrot, Dollfus, Trocmé, Tubiana, Teglas, Faye, Rouzioux, Blanche, 
Warszawski & Trocme 2013:492). Moreover, as Stirratt, Remien, Smith, Copeland, 
Dolezal, Krieger and Team (2006:490) explain, patients are more likely to default on 
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medication to avoid potential communication of their positive HIV status. Disclosure also 
encourages uptake of appropriate infant feeding options as it encourages exclusive 
breastfeeding by releasing pressure from the mother on early initiation of mixed feeding 
usually advocated for by the extended family in an African setup (Madiba & Letsoalo 
2013:8). Additionally, a woman whose spouse is aware of her HIV positive status is 
more likely to deliver at a health facility where they are likely to receive appropriate 
measures to lower the risk of MTCT (Kibera 2011:4572; Turan, Hatcher, Medema-
Wijnveen, Onono, Miller, Bukusi, Turan & Cohen 2012:e1001295). Finally, disclosure 
may enable HIV positive individuals gain access to appropriate treatment, motivate 
them to change risky behaviour patterns, and encourage their sexual partners to seek 
counselling and testing services. In a polygamous set up, disclosure may also protect 
the other spouses from being infected. These actions may ultimately lower the number 
of children being infected through their mothers. (Medley, Garcia-Moreno, McGill & 
Maman 2004:304; Nkya, Davies, Nzioka & Mithwani 2010:3). 
 
Due to these benefits, HIV positive clients, including those attending antenatal clinic, are 
routinely encouraged and supported to disclose their status, especially to their sexual 
partners (Jasseron et al 2013:495). However, this does not always happen, and is 
reflected in the varied disclosure rates among different populations and settings in 
Africa which range from as low as 16.7% to as high as 95% (Medley et al 2004:304). 
Comparing countries, the rates of disclosure are notably lower in developing countries. 
As reported by Maman and Medley (2011:6), in developing countries, the rates range 
from 16.7% to 86%, with an average rate of disclosure of 49%, a rate considerably 
lower than the 79% average rate reported from studies conducted in the developed 
world. This variance is also demonstrated in women, where those from developed world 
have an average rate of 71% compared to 51% in the developing world (Maman & 
Medley 2011:5). Importantly, and of direct impact to PMTCT is that the vital sub-group 
of pregnant women attending antenatal clinic are less likely to disclose their HIV status 
to their partners, as compared to the general population (Bachanas et al 2013:427).  
 
Considering the importance HIV status disclosure plays in promoting access, uptake, 
and adherence to PMTCT interventions, and the low partner disclosure rate among 
pregnant women attending antenatal clinic, it was paramount to conduct a study to 
determine whether an association exists between non-disclosure of positive HIV status 
to a partner and MTCT. Addressing partner non-disclosure, in the setting of an 
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association between non-disclosure and MTCT, could have an enormous impact on the 
spread of HIV among children considering MTCT accounts for 90% of childhood HIV 
infections. 
 
A review by Medley et al (2004:305) confirms that many studies on disclosure have 
focussed on patterns, fears and barriers to disclosure. The few studies that have directly 
focussed on the impact of non-disclosure to partners on MTCT have given conflicting 
and inconclusive results (Aluisio et al 2011:80; Bucagu, Bizimana, Muganda & Humblet 
2013:10; Jasseron et al 2013:494; Roxby, Matemo, Drake, Kinuthia, John-Stewart, 
Ongecha-Owuor, Kiarie & Farquhar 2013:35) This study was therefore conducted 
against the background of these inconclusive results, and paucity of data on the 
association between non-disclosure of HIV status to partners and MTCT. 
 
1.3 STATEMENT OF THE RESEARCH PROBLEM 
 
While significant steps have been taken towards PMTCT, non-disclosure of a HIV 
positive status to male partners by women threatens the success of PMTCT 
programmes. The low rates of HIV status disclosure reported among women in 
antenatal settings have several implications for PMTCT programmes as the optimal 
uptake and adherence to such programmes is difficult for women whose partners are 
either unaware or not supportive of their participation (Aluisio et al 2011:81). Studies 
have documented that disclosure rates remain low in developing countries (Bachanas et 
al 2013:427; Jasseron et al 2013:494; Maman & Medley 2011:5). While rates, barriers 
to, and outcomes of disclosure have been widely studied, few studies have assessed 
the association between non-disclosure of HIV status to partners and MTCT. The 
question that therefore arose was:  Is there an association between non-disclosure of 
HIV positive status to a partner, and MTCT at 6 weeks of age of the baby? 
 
1.4 PURPOSE AND OBJECTIVES OF THE STUDY 
 
1.4.1 Research purpose 
 
The purpose of the study was to determine, using a case-control study, whether a direct 
association exists between non-disclosure of HIV positive status to a partner and 
MTCT. 
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1.4.2 Research objectives 
 
The study sought to 
 
• determine the proportion of mothers who did not disclose their HIV positive status 
to their partner among mothers of HIV exposed infants who turned positive at 6 
weeks of age (case) 
• determine the proportion of mothers who did not disclose their HIV positive status 
to their partner among mothers of HIV exposed infants who remained negative at 
6 weeks of age (control) 
• compare the proportion of exposure (non-disclosure of HIV positive status) 
between cases and controls in order to determine the association between non-
disclosure of HIV positive status to a partner, and MTCT at 6 weeks of age 
• determine whether male partner involvement mediates the effect of non-
disclosure on MTCT 
• recommend strategies for disclosure and male partner involvement as part of 
PMTCT 
 
1.4.3 Research hypotheses 
 
• Among HIV exposed infants, infants who turn positive at 6 weeks are more likely 
to have a mother who has not disclosed her HIV positive status to her partner as 
compared to HIV exposed infants who remain negative.  
• Male partner involvement mediates the effect of non-disclosure on MTCT. 
 
1.5 SIGNIFICANCE OF THE STUDY 
 
The findings of this study inform the current body of research regarding the association 
between non-disclosure of positive HIV status by women to their partners and MTCT, 
providing suggestions on how to improve male partner involvement, and better disclose 
positive HIV status among pregnant women, without compromising on their safety and 
confidentiality. These contributions, will contribute to the overall reduction in MTCT. 
Finally, this study exemplifies how a case-control study can be used to show 
  
7 
association between two factors while demystifying the notion that a case-control study 
is too complex to be conducted by novice researchers.  
 
1.6 DEFINITION OF KEY CONCEPTS 
 
1.6.1 Partner 
 
Free Merriam-Webster Dictionary (2014) defines a partner as someone's husband or 
wife or the person someone has sexual relations with. In this study, a partner was 
referred to any male designated by the mother as the father to the baby, or one who she 
has a sexual relationship with and is involved in the care of the baby. 
 
1.6.2  HIV positive status 
 
A HIV positive person is one who is HIV infected based on a positive HIV antibody test 
(rapid or laboratory-based enzyme immunoassay), confirmed by a second HIV antibody 
test (rapid or laboratory-based enzyme immunoassay) relying on different antigens or of 
different operating characteristics (Baveewo, Kamya, Mayanja-Kizza, Fatch, Bangsberg, 
Coates, Hahn & Wanyenze 2012:154). In this study, any mother who is reported as HIV 
positive based on the outcome of HIV tests conducted at a health facility was deemed to 
be HIV positive. 
 
1.6.3 HIV exposed infant 
 
A HIV exposed infant is defined as infants and children aged less than 18 months born 
to mothers living with HIV (Sugandhi, Rodrigues, Kim, Ahmed, Amzel, Tolle, Dziuban, 
Kellerman & Rivadeneira 2013:s187). In this study, a HIV exposed infant was taken as 
a baby born to a HIV positive mother between January 2013 and June 2014, and who 
met the eligibility criteria of the study. 
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1.6.4 Non-disclosure 
 
The definition of non-disclosure by Maman and Medley (2011:3) as failure of informing 
another person or persons of ones HIV positive status was adapted in this study as 
failure of a mother with a baby born between Jan 2013 and June 2014 to disclose her 
positive HIV status to her partner. 
 
1.6.5 Male partner involvement 
 
In the context of PMTCT, a male partner is involved if he accompanies his pregnant 
spouse to antenatal clinic, receives counselling for HIV either individually or together as 
a couple and discloses his status to the partner, or provides financial assistance for 
partner’s hospital visits (Kalembo, Zgambo, Mulaga, Yukai & Ahmed 2013:e66517). In 
this current study the variable used as a proxy for male partner involvement was male 
partner attendance at antenatal clinic with his partner. 
 
1.7 CONCEPTUAL FRAMEWORK 
 
The study focussed on the relationship between an infant’s HIV status at 6 week of age 
and their mother’s disclosure of positive HIV status to her partner, with infant HIV status 
being the outcome variable and mother’s disclosure of positive HIV status to partner the 
predictor variable. Male partner involvement was hypothesised to affect the relationship 
between non-disclosure and infant HIV status, and was therefore the mediator variable 
(figure 1.1). Variables associated with the outcome and with a likelihood of being 
unevenly distributed between the cases and controls were measured: length/duration of 
relationship, parity of the mother, couple testing during pregnancy, awareness of 
partner’s HIV status and disclosure to other people. 
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Figure 1.1:  Relationship among variables 
 
1.8 RESEARCH DESIGN AND METHOD 
 
The section outlines the research design and methodology used in this study, with a 
more detailed description presented in chapter 3. 
 
1.8.1 Research paradigm 
 
To enable the researcher to test the hypothesis of whether an association between non-
disclosure of HIV positive status and MTCT exists, the positivist research paradigm was 
selected. The paradigm assumes a reality independent of human observation exists, a 
reality that can be measured objectively using an orderly disciplined procedure to test 
the researchers hypothesis about the nature of the phenomena being studied and the 
relationship among them (Polit & Beck 2012:15). The paradigm ultimately led to 
Confounding variables 
• Couple testing during 
antenatal clinic visit 
• Number of antenatal visits 
• Number of children 
• Disclosure to others (non-
partner) 
• Duration of relationship with 
partner 
 
Causal pathway 
• Sub-optimal feeding options 
• Non-attendance/reduced 
clinic attendance 
• Non-us/delayed  initiation of 
ARVs during pregnancy/ 
infant anti-retroviral 
prophylaxis 
 
Predictor variable 
Non-disclosure of 
positive status  
to partner 
Outcome variable 
Infant HIV status at 6 
weeks 
Mediating variable 
Lack of male partner 
involvement 
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adoption of the quantitative approach which studies phenomena by way of precise 
measurement and quantification involving a rigorous and controlled design (Weaver & 
Olson 2006:460). 
 
1.8.2 Research design 
 
A 1:4 matched case-control study, a type of analytical observational design which 
measures the exposure and disease occurrence without intervening (Polit & Beck 
2012:224) enabled the researcher compare the exposure level (non-disclosure of 
positive HIV status) between HIV positive and negative infants. 
 
1.8.3 Population 
 
1.8.3.1 Study population 
 
The study population was defined as HIV positive women and their exposed infants 
delivered between January 2013 and June 2014 in line with the definition by Curtis and 
Drennan (2013:236) study population being the total number of units from which data 
can potentially be collected from. 
 
1.8.3.2 Target population 
 
The target population from whom the researcher gathered information and generalised 
findings to were HIV positive women aged 15-49 years and their exposed infants on 
follow up at a HIV comprehensive care centre in the developing world. 
 
1.8.3.3 Accessible population 
 
The accessible population, defined as the aggregate of cases that conform to 
designated criteria and that are accessible as subjects for the study (Polit & Beck 
2012:274) was HIV positive women and their exposed infants, who were born between 
January 2013 and June 2014 and who had their HIV status determined by polymerase 
chain reaction test at 6 weeks of age, and were on follow up at a HIV comprehensive 
care centres within Siaya County, Kenya. 
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1.8.4 Sample and sampling procedure 
 
Sampling is the process of selecting a group of subjects for a study in such a way that 
the individuals represent the larger group from which they were selected. This 
representative portion of a population is called a sample (Polit & Beck 2012:275). A 
sampling frame on the other hand refers to the source material from which a sample is 
drawn. It is a list of all those within a population who can be sampled, and may include 
individuals (respondent sampling), households or institutions (site sampling) 
(Katzenellenbogen & Joubert 2007:106; Polit & Beck 2012:275).  
 
A list of all health facilities offering HIV comprehensive care in Siaya County served as 
the health facilities’ sampling frame, from which referral health facilities from each sub-
County was selected and included in the study. For respondent sampling, all HIV 
exposed infants in the year 2013/2014 on care at the selected facilities were identified 
from the HIV exposed infants cohort registers. For every case identified, four controls 
were identified by random sampling from the same register. 
 
1.8.5  Data collection 
 
Data collection is the capturing and translating of data so that the data can be analysed 
(Polit & Beck 2012:367). For this study the structured data collection approach was 
selected. The structured approach ensured that data were quantifiable by the use of 
numerical values. 
 
Review of records involves use of data collected routinely as part of patient care, and 
for this study, the HIV exposed infants database was used to identify HIV exposed 
infants, and the PCR test result at 6 weeks used to classify them as cases or controls.  
 
Self-reports was used to gather information from the respondents due to its ability to 
gather retrospective data about events occurring in the past hence specifically ideal for 
case-control studies (Katzenellenbogen & Joubert 2007:106). 
 
The data collection instrument of choice for this study was a structured questionnaire. A 
self-administered questionnaire, consisting of closed ended questions was used to 
collect information from respondents in this study. This questionnaire was pre-tested 
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using ten mothers from a hospital in Kisumu County to test the reliability, validity and 
cultural sensitivities of the questions.  
 
1.8.6 Data analysis 
 
The research was designed and analysed as a matched case-control study. In the 
analysis, the primary question considered was the degree of association between risk of 
MTCT and non-disclosure of positive HIV status, the extent to which the observed 
associations may have resulted from bias, confounding and/or chance, and the extent to 
which they may be described as causal. 
 
1.8.7 Validity and reliability 
 
Reliability is the extent to which measurements are repeatable when different persons 
perform the measurements, on different occasions, under different conditions (Drost 
2011:106). The use of a pre-test was a measure put in place to ensure reliability of the 
data collection tool. 
 
Validity on the other hand refers to whether the instrument is measuring what it was 
supposed to measure (Drost 2011:114).  To develop strong support for the validity, the 
researcher extensively reviewed existing literature prior to the questionnaire design to 
ensure broader subject matter knowledge on the research topic.  The questionnaire was 
designed and discussed with the study supervisor, and the questionnaire reviewed by a 
statistician to confirm the information that will be collected could be analysed. 
 
1.9 ETHICAL CONSIDERATIONS 
 
Ethical considerations refer to the protection of the rights of all those involved or 
affected by the research study. To protect the rights of the respondents, the three 
ethical principles of autonomy, beneficence/non-maleficence, and justice were upheld. 
The right to self-determination and full disclosure was ensured as well as the 
respondents’ right to fair treatment and privacy. 
 
To protect the institution, ethical clearance was granted by the Research and Ethics 
Committee, Department of Health Studies, UNISA on 29 October 2013 (see annexure 
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1). Local ethical approval was obtained from Moi University, College of Health Sciences 
Research and Ethics Committee on 3 March 2014 (see annexure 2). Permission to 
conduct the study in Siaya County was sought and granted by the County Director of 
Health (see annexure 3 and annexure 4). All facilities received a copy of the research 
proposal and copies of the ethical clearance certificates together with the request for 
permission to conduct the study at the institution. Additional verbal permission was 
obtained from the in-charges of the various health facilities.  
 
1.10 SCOPE AND LIMITATIONS OF THE STUDY 
 
The study focussed on determining whether non-disclosure of a positive HIV status to a 
male partner can have an impact on 6 week MTCT rates. The accessible population 
included HIV positive mothers and their babies who were born after January 2013, and 
had their 6 week PCR status determined.  
 
As with all research, this study had several limitations. As a case-control study, the 
focus is more on determining an association and as such generalisation of results to a 
broader population must be done with caution. There is also the risk on any self-
reported assessment that the results may be vulnerable to the reporting of socially 
desirable responses. The intended behaviour reported by the subjects, especially for 
those variables that are culturally sensitive such as infant feeding practices, mutual 
disclosure of HIV status and individual socio-economic characteristics may not be 
consistent with their real-life actions. In order to moderate these potential limitations, the 
respondents were assured anonymity and were encouraged to give honest responses. 
 
1.11 STRUCTURE OF THE DISSERTATION  
 
This dissertation is organised in chapters, each with a specific focus. The first chapter 
provides the background to the study, significance of the study and study question and 
objectives. It also described the research methodology, a brief literature review, study 
limitations, and an overview of ethical considerations. Chapter 2 is a review of the 
literature on HIV partner disclosure and MTCT. A summary of the related literature 
provides a framework for proceeding with the current study. The third chapter explains 
the methodological aspects, study design, data collection and the instruments used in 
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the study. Results of the study are discussed in chapter 4.  Chapter 5 provides a 
summary and interpretation of the findings, limitation and recommendations. 
 
1.12 CONCLUSION 
 
HIV disclosure among pregnant women is an important element in PMTCT as it allows 
women to make informed decisions regarding their babies and their own health. This 
chapter has provided background information on the study, clearly justifying the need 
for the current study. Additionally, the chapter provided a summary of the research 
process followed by the researcher, including the selection of a matched case-control 
analytical research design, and use of a structured self-administered questionnaire as 
the data collection instrument of choice. The chapter that follows is a detailed review of 
some of the literature available on non-disclosure and MTCT. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
 
2.1 INTRODUCTION 
 
Chapter 1 gave a summary of the key features of the study, in addition to providing a 
framework for the dissertation. This chapter provides an overview of previous research 
on non-disclosure and mother-to-child transmission, while explicating the mechanism 
through which non-disclosure impacts on MTCT. 
 
Research success depends to a large extent on how effectively the literature review is 
conducted. Not only does a well-conducted review create justification for the study, but 
also builds a solid understanding of the research area in terms of what has been done 
before, and the relationship among the various study variables. Moreover, the review 
allows for establishment of a conceptual framework and methodological focus (Curtis & 
Drennan 2013:54; Randolph 2009:2). Therefore, a literature review is “an evaluative 
report of studies found in the literature related  to a given proposed research  area” 
(Boote & Beile 2005:3).  
 
The procedure followed during a review is as important as the outcome, and the 
strategy should be adequately described in detail to the point where, if the strategy was 
to be reused, the same literature sources would be identified. For that reason, the step 
by step strategy adopted in this review is briefly described. 
 
To begin with, the research question for the literature review was framed: “From 
previous literature, does non-disclosure of a positive HIV status to a partner have an 
influence on MTCT?” Eligibility criteria of literature sources was then determined. Any 
study that reported results on at least one of the two study variables; disclosure of HIV 
status and MTCT was included. Additionally, the literature must have been written in 
English language not earlier than 2003 in line with the recommendation of Burns and 
Grove (2011:190) of obtaining documents for the previous ten years. Since the literature 
search began in January 2013, the search went back to January 2003. Nevertheless, 
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literature written prior to January 2003 were included if they were considered classic 
documents related to either the literature review topic or the methodology. The next step 
involved using the key terms; non-disclosure or disclosure and MTCT or vertical 
transmission, both singly and in combination to search for relevant documents (articles, 
books and teaching materials) using CINAHL, PubMed, and Google scholar. The 
search was conducted between January 2013 and April 2014. All identified documents 
were examined by reviewing the title and abstract, and those found relevant were 
retrieved for inclusion in the review. Reference lists of retrieved documents were 
additionally reviewed to identify additional publications that were relevant. The process 
of reference review was repeated until no new documents could be retrieved. 
 
The causal pathway adopted in this study is that HIV testing counselling and testing 
creates awareness of HIV status among pregnant women. The awareness thus created 
should enable the woman maximise PMTCT. While this is true, it is additionally 
necessary to secure the support of the male partner, which requires disclosure of HIV 
positive status by the pregnant woman. It is posited that with the full support of the 
partner, the woman will then be able to optimise PMTCT interventions, an action that 
will ultimately lower the risk of mother-to-child transmission of HIV. 
 
Therefore, this review is structured to first present background information on the 
burden of HIV among women and children in sub-Saharan Africa, aimed at 
demonstrating the importance of the research focus area. Antenatal HIV counselling 
and testing, male partner involvement and disclosure of HIV status, as strategies to 
reduce MTCT are followed by a demonstration of how the three strategies are linked to 
MTCT. Finally, a review of the case-control study design will be undertaken to 
demonstrate the appropriateness of the design in studying the problem area.  
 
At the end of this chapter, it is hoped that the structured discussion of the 
aforementioned literature areas will not only facilitate a critical understanding of the 
linkage between non-disclosure of positive status and MTCT, but also enable the reader 
to appreciate the focus and justification for this research.  
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2.2 HIV INFECTION AMONG WOMEN AND CHILDREN  
 
A lot has changed since the documentation of the first case of Acquired Immune 
Deficiency Syndrome (AIDS) among children in the early 1980s. The epidemiology of 
pediatric HIV transmission has been demystified, and it is now recognized that more 
than 90% of childhood infections are as a result of MTCT (The Independent Expert 
Panel 2010:7). The burden of the HIV epidemic has shifted towards women and female 
adolescents, with women constituting nearly half of all HIV/AIDS infections worldwide, 
58% of whom live in sub-Saharan Africa (Abdool Karim, Sibeko & Baxter 2010:S122). 
Furthermore, this burden is disproportionately distributed to young women aged 15-24 
years as compared to young men in the same age group. Out of the total number of 
people aged 15-24 years who are HIV infected, 71% are females representing a HIV 
burden 3-7 fold higher in adolescent women (Abdool Karim et al 2010:s122; Gouws, 
Stanecki, Lyerla & Ghys 2008:S5; Shetty 2013:81). As theorised by Breu, 
Guggenbichler and Wollmann (2012:1), the HIV epidemiologic shift towards women can 
only serve to increase new paediatric infections since MTCT is the most common 
source of HIV infection among infants and children.  
 
In 2012, an estimated 1.4 million pregnant women infected with HIV gave birth globally, 
with approximately 297,000 children born being newly infected with HIV; 91% of whom 
were in sub-Saharan Africa (Anoje, Aiyenigba, Suzuki, Badru, Akpoigbe, Odo, Odafe, 
Adedokun, Torpey & Chabikuli 2012:1). In Kenya, studies have reported MTCT rates of 
between 4% and 7% (Nyandiko, Otieno-Nyunya, Musick, Bucher-Yiannoutsos, Akhaabi, 
Lane, Yiannoutsos & Wools-Kaloustian 2010:44; Roxby et al 2013:35). However, these 
figures are thought to be underestimates owing to low HIV testing rates among HIV 
exposed infants. A recent nationwide survey reported a 16% rate among all the infants 
tested (Kenya National AIDS and STI Control Programme 2013:12). Due to these high 
rates, a lot of attention has been directed towards decreasing perinatal HIV 
transmission, with a goal of eventually eliminating MTCT.   
 
2.3 SOCIO-BEHAVIOURAL PMTCT STRATEGIES 
 
2.3.1 Antenatal HIV testing and counselling 
 
Maternal antenatal HIV testing is considered one of the core PMTCT interventions as it 
creates awareness of HIV status among pregnant women which is essential in providing 
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an entry point into PMTCT programme, an action considered the starting point for 
achieving low rates of mother-to-child transmission. (Aluisio et al 2011:79). 
Consequently, efforts to control vertical transmission have been directed first at 
increasing HIV status awareness among pregnant mothers. 
 
The “opt out” approach in HIV testing and counselling adopted by many countries has 
contributed to an increase in the number of pregnant women being tested and being 
aware of their HIV status (Baggaley et al 2012:637; Chandisarewa, Stranix-Chibanda, 
Chirapa, Miller, Simoyi, Mahomva, Maldonado & Shetty 2007:843). In this strategy, all 
pregnant women attending antenatal clinic are counselled and tested, unless they 
decline. Wettstein, Mugglin, Egger, Blaser, Vizcaya, Estill, Bender and Collaboration 
(2012:2367) review on the uptake of antenatal testing in 44 countries in sub-Sahara 
Africa using the opt out approach reported an average testing rate of 94%, an 
observation supported by two separate studies done in south Africa and Uganda where 
testing rates in both settings were above 90% (Byamugisha, Tumwine, Ndeezi, 
Karamagi & Tylleskär 2010:54; Horwood, Vermaak, Butler, Haskins, Phakathi & Rollins 
2012:171). In Kenya, a National survey revealed that out of the 96% pregnant women 
who attended antenatal clinic between 2007 and 2012, ninety-two percent had been 
tested for HIV (Kenya National AIDS and STI Control Programme 2013:17).The high 
uptake of antenatal HIV counselling and testing has resulted in increased HIV status 
awareness among pregnant women attending antenatal care.  
 
2.3.2 HIV positive status disclosure 
 
Optimal utilisation of all PMTCT interventions presents a much higher transmission risk 
reduction, and often depends on social support offered to HIV positive women. In  
patrilineal societies where male heads are still the primary decision makers, partner 
social support impacts on utilisation of health services (Gourlay, Birdthistle, Mburu, 
Iorpenda & Wringe 2013:8). However, for the support to be offered by the partner, 
disclosure must happen. 
 
Disclosure of HIV positive status is defined as revelation by a HIV positive person of his 
or her status to another person, usually of significance to him/her such as a sexual 
partner (Maman, Mbwambo, Hogan, Weiss, Kilonzo & Sweat 2003:375). Among HIV 
positive women, disclosure has been shown to provide emotional and psychological 
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support which increases acceptance, uptake, and adherence to PMTCT interventions 
resulting in increased survival and follow up among HIV exposed infants (Aluisio et al 
2011:81; Farquhar, Kiarie, Richardson, Kabura, John, Nduati, Mbori-Ngacha & John-
Stewart 2004:1625; Msuya, Mbizvo, Hussain, Uriyo, Sam & Stray-Pedersen 2008:705).  
Additionally, disclosure enables sexual partners to make informed reproductive health 
choices that may ultimately lower the number of unintended pregnancies among HIV 
positive and discordant couples which ultimately decreases the risk of HIV transmission 
to the unborn child (Maman et al 2003:377).  
 
In spite of the benefits of disclosure on MTCT, some pregnant women may decide to 
keep their positive HIV status a secret. Indeed, in women, disclosure of positive HIV 
status has been linked to several risks such as blame of infidelity, abandonment, 
separation and divorce, physical and emotional abuse, discrimination and stigma, as 
well as loss of custody of children and property (Masupe 2011:50). Such risks make 
decision to disclose one’s status a difficult one, more so in the context of opt out testing 
where the burden of disclosure is left on the infected woman (Masiye & Ssekubugu 
2008:343).  Still, HIV positive pregnant women, as part of antenatal counselling and 
testing are routinely advised to disclose their HIV status to their partners (Roxby et al 
2013:33; Sendo, Cherie & Erku 2013:768). But as Bachanas et al (2013:429) pointed 
out, disclosure in antenatal settings does not always happen. 
 
Medley, Garcia, Moreno, McGill and Maman (2004:304) in their systematic analysis 
reported that disclosure rates varies greatly between 16.7% and 86%, a variability that 
has persisted beyond 2004. Low disclosure rates have been demonstrated in several 
countries: 41% in Tanzania (Kiula, Damian & Msuya 2013:436), 49% in Kenya (Roxby 
et al 2013:34), and 66% in Zimbabwe (Mucheto, Chadambuka, Shambira, Tshimanga, 
Gombe & Nyamayaro 2011:53). Conversely, some countries have demonstrated high 
disclosure rates including 90% in Nigeria, 97% in Zimbabwe, 80% in Namibia, 
Tanzania, and Ethiopia (Igwegbe & Ugboaja 2010:298; Reda, Biadgilign, Deribe & 
Deribew 2012:3; Udigwe, Mbachu, Oguaka, Onyegbule, Udegbunam & Umeononihu 
2013:338). The variability in disclosure rates illustrated supports the singling out of non-
disclosure as one of the important non-chemo prophylactic factors that if not adequately 
tackled will continue to hamper efforts in the elimination of vertical transmission of HIV 
(Torpey, Mandala, Kasonde, Bryan-Mofya, Bweupe, Mukundu, Zimba, Mwale, Lumano 
& Welsh 2012b:e42859). 
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Several factors promote partner HIV status disclosure among women attending 
antenatal clinic. Couple testing by default removes the burden of disclosure on the 
woman as this approach assures mutual partner disclosure (Msuya et al 2008:707; 
Farquhar et al 2004:1625). If couple testing is not possible and the woman has been 
tested individually, it has been shown that repeated encouragement for disclosure at 
every clinic visit increases the chances of disclosure taking place (Sendo et al 
2013:769). Involvement and awareness of the partner status in the testing process also 
strongly influences the decision to disclose (Reda et al 2012:3). 
 
Other factors that enhance disclosure include nature of relationship with the partner. 
Women who are married and in a stable relationship are more likely to disclose (Osinde, 
Kakaire & Kaye 2012:63; Seid, Wasie & Admassu 2012:102) , especially if the partners 
are open to each other and the woman is aware of the partner’s status (Seid et al 
2012:103). For example, Kassaye, Lingerh and Dejene (2005:129), in a cross-sectional 
study found that the respondents who did not know the partner’s HIV status were 98% 
less likely to disclose to the partner. They also reported that women are additionally 
more likely to disclose to their partner if they have been in the relationship for a longer 
duration and are the primary partners. 
 
Characteristic of the woman can also impact on disclosure. A younger woman, more so 
if she has no other children is less likely to disclose (Kassaye et al 2005:125; Kiula et al 
2013:4; Olagbuji, Ezeanochie, Agholor, Olagbuji, Ande & Okonofua 2011:487). Kassaye 
et al (2005:125) also showed that less educated women were more likely to disclose 
their test results to sexual partners than more educated women. However, this varies by 
setting. For example, Osinde et al (2012:63) demonstrated that in Burkina Faso, women 
with higher education are more likely to disclose their HIV test result to their sexual 
partner than women who are illiterate.  
 
Another determinant of disclosure is duration of status awareness, with women aware of 
their status for a longer period of time being more likely to disclose (Kassaye et al 
2005:128). Finally, a woman who is currently on ARVs is more likely to have disclosed 
her status due to the fact that prior to being initiated on ARVs, disclosure for purposes 
of creating a support system is emphasised as part of adherence counselling (Stirratt et 
al 2006:488).  
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2.3.3 Male partner involvement  
 
Men are the decision-makers in many African countries where PMTCT services are 
offered (Kalembo et al 2013:e66517), and their involvement is crucial in the optimisation 
of PMTCT services. Many reports point to the beneficial effect of male partner support 
in antenatal HIV services on prevention of paediatric infections (Morfaw, Mbuagbaw, 
Thabane, Rodrigues, Wunderlich, Nana & Kunda 2013:8), and as Auvinen, Suominen, 
Valimaki & Välimäki (2010:308) point out, increased pregnant women's commitment to 
PMTCT interventions depends on the male partner’s support and commitment in all the 
phases of the PMTCT interventions. This support has been linked to optimisation of 
PMTCT services including, inter alia,  attendance to antenatal clinic, use and adherence 
to maternal and infant ARVs, adherence to infant feeding method selected, and 
increased follow up among HIV exposed infants (Jasseron et al 2013:488; Laher, 
Cescon, Lazarus, Kaida, Makongoza, Hogg, Soon, Miller & Gray 2012:94; Msuya et al 
2008:705; Roxby et al 2013:35; Varga, Sherman & Jones 2006:955). Ultimately, all 
these positive outcomes contribute to a lower vertical HIV transmission (Aluisio et al 
2011:76; Villar-Loubet et al 2013:265).  
 
Moreover, male partner involvement has been shown to increase acceptance of HIV 
testing and the results thereof (Bolu, Allread, Creek, Stringer, Forna, Bulterys & Shaffer 
2007:s85).  Men involvement also allows for shared responsibility for preventing HIV 
transmission to the unborn child, and adoption of safer sex practices (Medley et al 
2004:305), while also playing the crucial role in supporting HIV positive pregnant 
women, by assisting them to get to clinics or hospitals where chances of safe delivery 
are higher (Haile & Brhan 2014:66). 
 
2.3.3.1 PMTCT clinics attendance 
 
Antenatal clinic attendance is crucial in early detection of HIV infection among pregnant 
women, and the male partner is key in ensuring this happens. The male partner will not 
only determine whether a pregnant woman attends antenatal clinic, but will also 
influence whether the first antenatal visit will be attended early in pregnancy and 
whether the woman will honour subsequent clinic appointments (Brusamento, 
Ghanotakis, Tudor, Van-Velthoven, Majeed & Car 2012:5; Kebaabetswe 2007:357; 
  
22 
Jasseron et al 2013:492). For example, in Uganda women who were economically 
dependent on their male partners had challenges in attending antenatal clinic (Duff, 
Kipp, Wild, Rubaale & Okech-Ojony 2010:39).  Therefore, as demonstrated by Bobrow 
(2008:1), gaining support of the male partner for the HIV pregnant woman is key in 
ensuring initial and subsequent PMTCT clinic attendance.  
 
2.3.3.2 Uptake of infant and maternal prophylaxis 
 
Early and consistent use of anti-retroviral drugs (ARVs) is known to dramatically lower 
the risk of MTCT (Ahmad 2011:980; Koye & Zeleke 2013:402). However, several 
factors including non-disclosure of positive status to a male partner tends to inhibit the 
use of ARVs. Indeed it is believed that the strong association noted between non-
disclosure of positive HIV status and poor use of maternal and infant ARV prophylaxis 
may partly reflect the difficulties experienced due to absence of male partner support 
(Jasseron et al 2013:494; Kuonza, Tshuma, Shambira & Tshimanga 2010:4).  Several 
studies have confirmed that non-disclosure could deter HIV positive women from 
obtaining, using or storing ARVs for maternal prophylaxis and from seeking/ 
administering infant prophylaxis (Delvaux, Elul, Ndagije, Munyana, Roberfroid & 
Asiimwe 2009:227). As Duff et al (2010:42) discusses, non-disclosure of HIV positive 
status is a major barrier to accessing and accepting highly active antiretroviral therapy 
(HAART) by HIV positive mothers. Varga et al (2006:954) affirms this by reporting that 
most women who choose to disclose do so anticipating that the disclosure will reduce 
the barrier on the use of ARVs for maternal and infant prophylaxis, since hiding of HIV 
status makes taking of ARV medicine a challenge (Kasenga, Hurtig & Emmelin 
2010:29). Msuya et al (2008:704) also demonstrates that support of male partner is 
directly linked to higher use of nevirapine for infant prophylaxis, a fact further supported 
by Koye and Zeleke (2013:398) and Gourlay et al (2013:13). Additionally, non-
disclosure is associated with higher rates of non-completion of PMTCT regimens 
(Jasseron et al 2013:491; Kirsten, Sewangi, Kunz, Dugange, Ziske, Jordan-Harder, 
Harms & Theuring 2011:4). This pattern reflects the impact keeping HIV infection status 
secret has on compliance with antiretroviral therapy. 
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2.3.3.3 Adherence to safe infant feeding options 
 
Compared to mixed feeding, exclusive breast feeding is an affordable, culturally 
acceptable, and effective means of lowering the risk of post-natal transmission while 
maintaining the overwhelming benefits of breastfeeding (Anoje et al 2012:4; Coutsoudis, 
Kwaan & Thomson 2010:1165; Kumwenda, Hoover, Mofenson, Thigpen, Kafulafula, Li, 
Mipando, Nkanaunena, Mebrahtu, Bulterys, Fowler & Taha 2008:124). Consequently, 
HIV positive mothers are usually advised to observe exclusive breastfeeding. However, 
in African settings, mothers are known to introduce supplementary feeds as early as 
when the baby is one months old substantially increasing the risk of HIV transmission 
(Madiba & Letsoalo 2013:8).  
 
Mothers aware of this risk usually strive to observe exclusive breastfeeding, but usually 
receive pressure from either the partner or other family members to introduce other 
foods. This makes exclusive breastfeeding in an area of HIV secrecy to be difficult due 
to familial pressure. As Msuya et al (2008:705) reported, women receiving support of 
their partners are more likely to avoid mixed feeding and adhere to the infant feeding 
method selected. Moreover, Muluye, Woldeyohannes, Gizachew and Tiruneh (2012:243 
also found out that husband’s preference was influential in the choice of infant feeding 
adopted, where if support was present, the mother was more likely to breastfeed. 
 
2.4 PARTNER NON-DISCLOSURE AND MTCT 
 
Few studies investigating the direct relationship between partner involvement and non-
disclosure of positive HIV status to a partner and MTCT exists and warrant in-depth 
discussion (Aluisio et al 2011; Bucagu et al 2013; Jasseron et al 2013; Roxby et al 
2013; Torpey et al 2012b:e42859). 
 
Aluisio et al (2011) were the first to document the benefits of male partner involvement 
in prevention of infant HIV acquisition. Through a prospective study of 456 women 
conducted between 1999 and 2005 in Nairobi, Kenya the researchers were able to 
demonstrate that male partner involvement significantly lowered risk of HIV acquisition. 
The researchers attributed the reduced risk to better adherence of antiretroviral 
medicine and more uptake of formula feed for infants. They also suggest that the 
reduced risk could be attributed to increase financial, physical and/or psychosocial 
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support for the HIV infected pregnant woman and her infant. One limitation though was 
that the sampling strategy was not adequately described to enable determination of the 
power of the study.  
 
Bucagu et al (2013) findings were similar to that of Aluisio et al (2011). They reported 
that non-disclosure of HIV status to partner emerged as an important factor for MTCT. 
In this prospective cohort study conducted at Muhima Health Centre in Kigali, Uganda, 
8,669 pregnant women who attended antenatal visits and screened for HIV were 
followed between May 2007 and April 2010. One limitation with the study was, as with 
all longitudinal studies, long time passage since cohort accrual might confound the 
association between the variables under study. 
 
A study in Zambia by Torpey et al (2012b:e42859) support studies by Aluisio et al 
(2011) and Bucagu et al (2013). In their analysis of DNA Polymerase Chain Reaction 
(PCR) results and client information on all dried blood samples from perinatally exposed 
infants 0 to 12 months of age sent to a central PCR laboratory between September 
2007 to January 2009, they reported that HIV status among infants was significantly 
associated with disclosure of HIV status to partner both at 6 weeks and 6 months of 
age. However the association did not exist where both mother and infant received 
intervention. The only limitation to the study by Torpey, Kabaso, Weaver, Kasonde, 
Mukonka, Bweupe, Mukundu and Mandala (2012a:27) is that they excluded infants not 
brought to facilities for their immunisation, and this could result in selection bias. 
 
Roxby et al (2013), however, contradicts the findings of the three aforementioned 
studies. In their study conducted in Nairobi, Kenya, HIV positive pregnant women HIV 
transmission risk was comparable between those who disclosed as compared to those 
who did not disclose to their partners. The study’s conduct within a primary study not 
designed to assess disclosure as a primary outcome could have limited the findings as 
the intervention of the primary study could have confounded the association between 
non-disclosure and MTCT resulting in a generally better adherence of PMTCT 
interventions as compared to those not in the study. In addition, exclusion of 
respondents who did not have Herpes simplex virus-2 (HSV) could have resulted in 
exclusion of HIV positive women and a possible selection bias. Finally, the small 
number of transmission events in the study made it impossible to exclude anything due 
to associated low statistical power. 
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To further complicate matters, despite  finding an association between non-disclosure 
and non-optimal PMTCT (late initiation of antiretroviral therapy, detectable viral load at 
delivery and lack of neonatal prophylaxis), Jasseron et al (2013) in their French 
Perinatal Cohort study of HIV infected pregnant women reported no difference in 
transmission rates based on disclosure status. Interestingly, the lack of association 
between non-disclosure and MTCT was explained by the economic independence of 
the women, higher level of care and availability of ARVs factors. Consequently, the 
authors cautioned on generalisation of these findings to a developing country setting. 
On a downside, as with the aforementioned studies, the 1.0% MTCT rate might have 
nulled the non-disclosure-MTCT effect. 
 
The above-mentioned studies have identified several other points of interest to this 
current study: The mechanism through which non-disclosure influences MTCT, and 
factors which could independently be associated with either MTCT and/or non-
disclosure, and therefore act as possible confounders in this current study. These 
factors will be briefly discussed to give the reader insight into why these factors are 
important in the current study. 
 
2.5 CLINICAL AND BIOLOGICAL RISK FACTORS FOR MTCT 
 
Several studies have demonstrated that MTCT is strongly associated with several 
maternal factors. These factors include: stage of HIV infection, represented by CD4 
count and viral load, use of HAART, and route of delivery (Ahmad 2011:981; Mucheto et 
al 2011:4). Maternal viral load remains the major biological determinant of MTCT , with 
total viral suppression (below 40 copies/mL) providing the most protective effect against 
MTCT (Charurat, Datong, Matawal, Ajene, Blattner & Abimiku 2009:9). In areas where 
viral load is not available, Maternal CD4+ count has been found to be associated with 
increased MTCT (Bucagu et al 2013:8; Toro, Katyal, Carter, Myer, El-Sadr, Nash & 
Abrams 2010:515). As a result, use of antiretroviral therapy (ART) during pregnancy 
decreases HIV replication, thus reducing rates of virus transmission (Ahmad 2011:981). 
 
Great controversy still exists regarding the best route of delivery in HIV infected 
pregnant women. Caesarean delivery has been shown to offer significant reduction in 
the risk of MTCT as compared with vaginal delivery (Brocklehurst 2002:102). However, 
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more recently, Torpey et al (2012a:29) demonstrated that vaginal delivery did not have 
a higher risk of transmission when both the mother and baby received ARV prophylaxis. 
However, if Invasive delivery procedures, for example episiotomy, are undertaken the 
risk of transmission is increased (The Independent Expert Panel 2010:12).  
 
Regarding the newborn, failure to receive oral zidovudine/nevirapine in the neonatal 
period, low birth weight, small for gestational age, late enrolment to the follow up clinic 
and home delivery are considered to present an increased risk of transmission 
(Charurat et al 2009:10; Delicio, Milanez, Amaral, Morais, Lajos, e Silva & Cecatti 
2011:40; Koye & Zeleke 2013:397).  
 
2.6 CONCLUSION 
 
Review of literature has demonstrated that non-disclosure of HIV positive status by a 
HIV positive mother to her partner is a real challenge and if not adequately addressed 
could hamper efforts in the elimination of MTCT. The review has also highlighted how 
non-disclosure could influence MTCT, through male partner support, which determines 
optimal utilisation of essential PMTCT interventions. The few studies that have 
evaluated the association between non-disclosure and MTCT were reviewed. All of 
them were limited by low transmission events that eventually impacted on the power of 
the studies. Moreover, the results were conflicting, creating need for further research 
that evaluates the direct association of non-disclosure and MTCT. Therefore, an 
empirical research using a case-control design which is appropriate for studying 
diseases with low disease outcome was adopted. 
 
The next chapter will detail the research methods used to capture the empirical data, 
including details on the research strategy to be adopted, data collection techniques and 
sample selection procedures used. 
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CHAPTER 3 
 
RESEARCH DESIGN AND METHOD 
 
 
3.1 INTRODUCTION 
 
The previous chapter discussed at length previous studies touching on the current 
research problem. The design and methodology used to determine whether an 
association between non-disclosure of positive HIV status to a partner and MTCT exists 
is discussed in this chapter. The chapter covers the research paradigm, the strategy for 
inquiry, study population and sampling technique used, data collection method and 
instrument, ethical considerations, validity and reliability, and data analysis plan. 
 
3.2 RESEARCH DESIGN 
 
The research paradigm, strategy for inquiry, and the methods all contribute to a 
research design that tends to be quantitative, qualitative, or mixed (Creswell 2014:7). 
The quantitative design, adopted in this study is explored in this section. 
 
3.2.1 Research paradigm 
 
Weaver and Olson (2006:460) define a research paradigm as “a set of beliefs and 
practices which regulates inquiry within a discipline by providing lenses, frames, and 
processes through which an investigation is accomplished”, and although not commonly 
expressly stated in the literature world, Creswell (2014:3) defines a research paradigm 
as “a set of beliefs and practices which regulates inquiry within a discipline by providing 
lenses, frames, and processes through which an investigation is accomplished”, and 
although not commonly expressly stated in the literature world, the author advises 
researchers to make explicit the larger philosophical ideas they espouse as this 
information explains why a given research approach was adopted. 
 
For the current study the positivist paradigm was adopted for several reasons. First, the 
positivist paradigm believes in determinism where causes determine an outcome, a 
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feature that resonated well with the study problem area, allowing the determination of 
whether non-disclosure contributes to MTCT. Secondly, the paradigm allowed the 
researcher to breakdown the broad concept of MTCT and only study the effect of non-
disclosure owing to the reductionism principle that ideas can be reduced into small 
discrete sets of ideas to test. Besides, the researcher had control over the choice of the 
research problem, research methodology, and variables to be studied, and had control 
over the effect of extraneous variables, all which are acceptable in the positivist view. 
Logical, deductive reasoning that involves generating conclusions from a sample was 
invoked to generalise findings from a subset of HIV positive women and their babies to 
a larger population. Finally, structured data collection and statistical analysis, both which 
appeal to the researcher were possible in positivism (Creswell 2014:7).  
 
3.2.2 Strategies of inquiry 
 
Philosophical assumptions are operationalised by adoption of specific strategies of 
inquiry which provide specific direction for procedures in a research design. Three 
strategies espouse the positivist worldview: true experiments, quasi-experiments and 
correlational studies (Creswell 2014:15).  
 
The researcher chose a non-experimental approach since for the research problem, it 
would be morally unacceptable and undesirable to manipulate any part of the study. 
Moreover, it was desirable to capture the phenomenon as it occurred without any 
intervention. Consequently, the researcher observed HIV positive mothers and their 
babies without manipulation of the independent variable. 
 
3.2.2.1 Case-control study 
 
Vanderbroucke and Pearce (2012:1480) and Marshall (2004:612) explain a case-control 
study as an investigation to the extent in which persons selected because they have a 
specific disease (the cases) and comparable persons, who do not have the disease (the 
controls) have been exposed to the disease's possible risk factors in order to evaluate 
the hypothesis that one or more of these risk factors is a cause of the disease. For this 
study, the design was used to compare the exposure level (non-disclosure of positive 
HIV status to a partner) between HIV exposed infants who turned positive at 6 weeks 
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(cases) and those who remained negative at 6 weeks (controls), to determine whether 
partner non-disclosure of positive HIV status to a partner is a risk factor for MTCT.  
 
The case-control design was selected for this study due to the strengths it offers. 
Foremost is that the case-control design enabled the researcher to study MTCT, which 
is a rare outcome, more so with the success of PMTCT interventions. Secondly, since 
the case-control design can be used to study a variety of exposures, it allowed for the 
study of non-disclosure of positive HIV status, which is a behavioural risk factor. 
Another advantage of the case-control design was its efficiency. The researcher was 
able to study the association in a short time and with minimal costs because the 
outcome of interest was already present and time was not spent waiting for an outcome 
to occur. Besides, only pre-existing data was gathered on relatively few subjects (Sayed 
2007:346). Lastly, the ability to match in case-control studies allowed the researcher to 
increase the power of the study to achieve a higher precision of the estimate measure 
by allowing the confounding variable be evenly distributed in both cases and controls. 
 
On the other hand, despite its practicality, the researcher was aware of the inherent 
limitations in the design which makes a case-control study one of the most challenging 
to design and conduct. The threats to validity were well anticipated and addressed as 
discussed in the enhancing research rigour section. Though in summary, the first major 
area where a case-control study presents a difficulty is in the selection of cases and 
controls. It becomes a problem if for some reason, cases (or controls) are included in 
(or excluded from) a study because of some characteristic they exhibit which is related 
to exposure to the risk factor under evaluation. In the current study, the sensitivity and 
specificity of the PCR testing currently being used to test for HIV in infants makes it less 
likely to classify cases as controls or vice-versa (Shah 2006:198). 
 
Another difficulty in case-control studies involves the measurement of exposure 
information. Cases often remember exposures to putative risk factors differently than 
controls. This differential recall (recall bias) can lead to information bias which could 
potentially generate an exaggerated relation between exposure and disease. The time 
period of exposure in this study was limited to less than 2 years to reduce the chance of 
differential recall of exposure in cases and controls. Bias from data gatherers presents 
further difficulties. If the individuals gathering information know the case or control 
status of the respondents, they might delve more deeply into a case’s background than 
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a control’s to obtain a hypothesised exposure. The data collectors were masked on the 
status of the respondents. Moreover the fact that the questionnaire was self-
administered also mitigated against this potential bias (Schulz & Grimes 2002:432). 
 
3.2.3 Research methods 
 
The third major element in the research design is the specific research methods that 
involve the forms of data collection, analysis, and interpretation that researchers 
propose for their studies. The quantitative methodology shares its philosophical 
foundation with the positivist paradigm and was consequently adopted for the purpose 
of predicting an association between the two key variables in this study.  
 
3.2.3.1 Research setting 
 
The study was conducted in Kenya within Siaya County. Kenya is one of the East 
African Countries lying between 5º north and 5º south of the equator. It is bordered by 
Ethiopia to the North, Somalia to the Northeast, Tanzania to the south, Uganda and 
Lake Victoria to the west, and Sudan to the northwest. The Indian Ocean borders it on 
the East. The country is divided into 47 counties within a total area of 582,646 square 
kilometres.  
 
Siaya County is one of the 47 counties in Kenya with a total surface area of 2,530 km2. 
It is located in the western parts of Kenya, bordering Lake Victoria to the East (figure 
3.1). It is divided into six administrative sub-counties namely; Gem, Ugunja, Ugenya, 
Siaya, Bondo and Rarieda. The country has a total population of 885, 762 persons 
comprising 419,227 males and 466,535 females, with 65.3% of the population being 
below 24 years.  
 
Siaya country has some of the worst HIV indicators in the country with a HIV prevalence 
rate of 19.1% and a MTCT rate of 15% (Kenya National AIDS and STI Control 
Programme 2013:4). The current child mortality rates for the county (NNMR 39/1000 
live births, IMR 111/1000 live births, U5MR 159/1000 live births) are among the highest 
in the country, with majority of these deaths being as a result of HIV/AIDS and 
malnutrition. 
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The major health care provider in Kenya is the Ministry of Health. The public delivery 
system is organised in a traditional pyramidal structure. First-level care is provided at 
dispensaries and medical clinics. The next level comprises health centres and sub-
County referral hospitals. Third-level care is provided at County referral hospitals, with 
two National Hospitals offering the highest level of care. Siaya County has one County 
referral hospital, six sub-County referral hospitals, 38 health centres, 98 dispensaries, 
and 12 clinics (Siaya County Health Strategic and Investment Plan 2013:7). 
 
Figure 3.1:  Map of Kenya showing Siaya County 
 
3.2.3.2 Population 
 
The target population refers to a complete set of elements (persons or objects) to whom 
the researcher would like to generalise the study’s findings (Polit & Beck 2012:274). The 
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findings in this study were generalised to HIV positive women and their exposed infants 
receiving HIV care and treatment at a health facility. 
 
The accessible population on the other hand is a set of persons from where  
respondents taking part in the study are selected from (Polit & Beck 2012:274). For the 
study, the accessible population was HIV positive mothers and their infants receiving 
care and treatment at a health facility within Siaya County. 
 
3.2.3.3 Eligibility criteria 
 
The eligibility criteria for the study population included the following: 
 
• HIV positive mother who gave birth to a baby between January 2013 and June 
2014. 
• The mother should have been in a relationship with a person of the opposite sex, 
either during pregnancy or for any period after delivery of the baby.  
• The mother-baby pair was receiving HIV care and treatment at a public health 
facility in Siaya County. 
• The mother-baby pair was resident in Siaya County. 
• The HIV exposed infant had the 6 week polymerase chain reaction (PCR) test 
done and results are available. 
 
3.2.3.4 Sampling 
 
According to Polit and Beck (2012:275), sampling is the process of selecting a group of 
subjects for a study in such a way that the individuals represent the larger group from 
which they were selected, usually done by selecting from a list of all those within a 
population who can be sampled, and may include individuals (respondent sampling), 
households or institutions (site sampling) (Katzenellenbogen & Joubert 2007:106). This 
representative portion of a population constitutes a sample.   
 
3.2.3.4.1 Site sampling 
 
Siaya County was stratified into six zones in line with the administrative sub-County 
divisions. From each of the sub-Counties, the sub-County referral health facility was 
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selected and included in the site sample. The approach was adopted since the referral 
facilities’ catchment population covers the entire county, and majority of HIV positive 
women seek care from these high volume facilities (Siaya County Health Strategic and 
Investment Plan 2013:7). 
 
3.2.3.4.2 Individual sampling  
 
HIV exposed infants born between January 2013 and June 2014 in the six selected 
facilities were identified by reviewing Government of Kenya HIV exposed infants’ cohort 
register which captures all infants born to HIV positive mothers. The registers are 
available at the facility level. The identified HIV exposed infants provided the sampling 
frame. 
 
• Selection of case and control groups 
 
Incidence density purposive sampling was used in the selection of cases (Curtis & 
Drennan 2013:241). Purposive sampling allowed for conscious and deliberate 
identification of infants who were HIV positive and fulfilled the eligibility criteria. Since 
the cases were newly diagnosed, they represented incident cases for the study period. 
A case consequently was identified as an infant born to a HIV positive mother within 
January 2013 to June 2014, and who had a positive PCR result at 6 weeks of age.  
 
Simple random sampling was used to select “potential” controls from the sampling 
frame. A control was defined as an infant born to a HIV positive mother within the same 
time period, and who had a negative PCR result at 6 weeks. For every case identified, 
four controls were included from the same facility to increase power in the analysis. 
 
• Sample size 
 
In order to be able to detect statistically significant results, it is important  to power the 
study adequately by determining the number of respondents required for the level of 
power desired (Curtis & Drennan 2013:156; Sayed 2007:346). In the current study, a 
difference in proportions formula for matched case-control studies was used. The 
formula considers type I and Type II errors, prevalence of exposure to the risk factor, 
and the odds ratio that one regards as important to detect. The following formula was 
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used to calculate the minimum required sample size (Edwardes 2001:13; Kim, Xue & 
Du 2006:929). 
 
For this study the following assumptions were made in the calculation of the sample 
size; 
• Power of 0.80, with an equivalent Zβ of 0.84 
• Significance level of 0.05, with a Zα of 1.96 
• Least extreme odds ratio to be detected of 2 
• Ratio of control to cases of 4:1 
• The proportion exposed in the control group is 15% 
• The Proportion of exposed in the case group used was 40%  
• Average proportion exposed = (Pcaseexp+ Pcontrolsexp)/2=0.275 
  
    =36 pairs (36 cases and 144 controls) matched in the ratio 1:4 
 
3.2.4 Data collection 
 
Data Collection is an important aspect of any type of research study. This is because 
inaccurate data collection can impact the results of a study and ultimately lead to invalid 
results. Data can be obtained from primary or secondary sources, both of which were 
utilised in the current study (Polit & Beck 2012:293).  
 
The data for this study was gathered retrospectively, with the use of a questionnaire 
which was developed to achieve the research aim and objectives (see annexure 6). 
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Primary data was obtained from respondents while secondary data included data from 
health facility records collected for routine care of patients. 
 
3.2.4.1 Data collection instrument 
 
Following a rigorous literature review, it was determined that no instrument could be 
used to adequately address the research purpose and objectives. Consequently, the 
researcher resolved to develop a new tool for eliciting the required information from 
respondents. 
 
The questionnaire, defined as a “printed self-report form designed to elicit information” 
(Burns & Grove 2011:353) was developed by following a defined process (Rattray & 
Jones 2007:235). The process involved making a decision on the information required, 
deciding on the question content, developing question wording, ordering the questions 
in meaningful order and format, pre-testing the questionnaire and development of the 
final questionnaire. 
 
3.2.4.1.1 Development 
 
The first step in questionnaire development was to decide the information that the 
researcher required to get from the respondents in order to meet the study’s objectives. 
The researcher had an idea about the kind of information to be collected, but sought 
additional help from secondary data. This review focussed on work that had been done 
on the same or similar problems area, identifying factors that had not yet been 
examined. Further, the researcher’s interaction with the respondents gave insight onto 
what information could be required.  
 
3.2.4.1.2 Compilation of the questions  
 
The information needed was then translated into questions that could elicit the desired 
information. A mix of open- and closed-ended questions was developed. Each potential 
question was screened with respect to (1) how the answers will be analysed (2) the 
anticipated information provided and (3) how the ensuing information would be used. 
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Next, the questions were assessed for their administrative viability or how respondents 
might react to them by considering three key questions: (1) Can respondents 
understand the question? (2) Can respondents answer the question? and (3) Will 
respondents answer the question? The focus was that the questions be amenable to 
being self-administered.  
 
The questionnaire was then structured, guided by the study problem, purpose and 
objectives. The questions were ordered in a logical sequence to allow for meticulous 
documentation of events. The language of communication was English and the same 
tool was used for all the subjects.  
 
3.2.4.1.3 Piloting the questionnaire 
 
After development, the questionnaire was subjected to a pre-test to enable the 
researcher to determine: 
 
• whether the questions as worded would achieve the desired results 
• whether the questions had been placed in the best order 
• whether the questions were understood by the respondents 
• whether additional questions were needed or whether some questions should be 
eliminated 
 
A small number of respondents, from a neighbouring County, with similar socio-
demographic profile as Siaya County was selected for the pre-test. Following the pre-
test, modifications were made in the grouping, sequencing, and coding of the questions. 
The final questionnaire was divided into the following sections (see annexure 6):  
 
Section A: Personal characteristics  
Section B: Infant characteristics 
Section C: Disclosure and HIV status 
 
3.2.4.2 Ensuring rigour of the study: reliability and validity 
 
In the following section the validity and reliability as applied to this research is 
discussed. 
  
37 
3.2.4.2.1 Validity 
 
The conclusion drawn from studies is based on information collected using a data 
collecting instruments. Therefore, ensuring the quality of these instruments is critical 
(Curtis & Drennan 2013316; Fraenkel & Wallen 2003:158). Validity in research 
addresses the issue of whether the findings of a study is believable and true and 
whether it evaluated what it was supposed to evaluate (Drost 2011:114; Rattray & 
Jones 2007:238). 
 
There are several different types of validity. Content validity (or face validity) refers to 
expert opinion concerning whether the scale items represent the proposed domains or 
concepts the questionnaire is intended to measure. Face validity refers to face 
judgement on whether the items in the questionnaire appear to represent the construct 
and whether the test or the instrument looks valid (Curtis & Drennan 2013:186; Mostert 
2007:339). 
 
Validity in the current study was assured by undertaking a thorough conceptualisation of 
the key constructs by conducing of a thorough literature review to ensure the 
questionnaire captured the full content domain and to ensure that the researcher had a 
broader knowledge on what has already been studied on the subject. The constructed 
questionnaire was additionally reviewed by a biostatistician, the ethical review panels, 
and the researcher’s supervisor to ensure content validity.  
 
3.2.4.2.2 Reliability 
 
It is essential that the reliability of a questionnaire be demonstrated. Reliability is the 
extent to which measurements are repeatable when different persons perform the 
measurements, on different occasions, under different conditions (Drost 2011:106). To 
reinforce and assess the reliability of the instrument in this research, evaluating test-
retest reliability assessed stability. The same questionnaire was used twice and a 
comparison of the responses assessed. The majority of respondents (90%) responded 
in the same manner to more than 95% of the questions. This was deemed adequate.  
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3.2.4.3 Data collection approach and method 
 
The researcher relied on a combination of two methods to gather information: use of 
instruments and collection of existing data from medical records. 
 
3.2.4.3.1 Review of records 
 
Review of records involves the use of data collected routinely as part of patient care. 
Following  ethical approval, and after obtaining consent from the Director of Health, the 
County HIV exposed infants’ database was accessed and used to classify exposed 
infants into either cases (positive HIV status at 6 week) and controls (negative HIV 
status at 6 weeks). Medical records of the potential respondents were then extracted to 
enable the researcher get contact details of the potential respondents. 
 
A major limitation of records is that completeness and accuracy may be compromised 
because the information is being recorded for other purposes. However, due to 
sensitivity of the research focus (mother-to-child transmission [MTCT]), the HIV 
exposed infant registers and individual records are usually well completed, and as such 
the researcher had confidence in the accuracy and completeness of the records. 
 
3.2.4.3.2 Questionnaire 
 
Once the respondents were identified, mothers to the infants (both cases and controls) 
were contacted to arrange for collection of exposure information. The respondents were 
presented with a list of questions to which they were to respond to. They were guided 
by the researcher, where necessary. Information collected included demographic details 
of the mother, disclosure of HIV status to the partner, disclosure to others who is not a 
partner, whether couple testing was done during clinic visits, whether the HIV status of 
the partner is known, and the duration of the relationship with the partner.   
 
The use of a questionnaire was favoured due to the increased reliability of information 
collected since data is collected in a structured manner (Curtis & Drennan 2013:300; 
Parahoo 2006:148). In addition, it allowed for quick data collection in an inexpensive 
and standardised manner (Rattray & Jones 2007:234). On the other hand, the 
researcher was aware that the respondents may report inaccurate information in 
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questions involving embarrassing or socially unacceptable behaviours. A questionnaire 
offers anonymity which can help towards obtaining candid results (Katzenellenbogen & 
Joubert 2007:106). Moreover, the researcher identified a private location in each health 
facility for respondents to fill the questionnaire, prior to which they were assured of 
anonymity and confidentiality of the data collected.  Refer to section 4.3.1 for response 
rate. 
 
3.2.5 Data analysis 
 
The research was designed and analysed as a case-control study. In the analysis, the 
basic question considered was the degree of association between an infant’s risk of 
being HIV positive at 6 weeks of age and non-disclosure of positive HIV status to a 
partner, with consideration being made on the extent to which the observed 
associations may have resulted from bias, confounding, and/or chance, and the extent 
to which they may be described as causal. The steps followed in the analysis of data 
are presented below. 
 
3.2.5.1 Exploratory data analysis 
 
Before onset of analysis, editing and cleaning of the data was undertaken to minimise 
data errors. This was based on the explanation by Heagerty, Kung-Yee and Zeger 
(2013:6) on the importance of exploratory data analysis, as it  not only allows one to 
visualise patterns in data and therefore be able to identify unusual observations, but 
also aids in detection of missing data on exposure, outcome, and other relevant 
variables. Moreover, exploratory analysis assists in the discovery of systematic 
relationships that are relevant to the study hypothesis. Once the errors were corrected, 
the analysis was directed towards determining the data distribution by plotting normality 
graphs for continuous variables for both case and control groups. The results of the 
analysis are shown in the results section.  
 
3.2.5.2 Univariate and multivariate analysis 
 
After exploratory data analysis, univariate analysis was performed to identify differences 
between the case and the control groups using Student’s t-test (continuous data) or the 
chi-square test (categorical variables) as appropriate.  Mantel-Haenszel summary odds 
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ratio and 95% confidence intervals for the odds ratio for the matched-pair data was 
calculated for each 2X2 table and Cochran-Mantel-Haenszel chi-square test used to 
test for its significance according to the formulas: 
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Statistical significance was defined as p<0.05. Conditional logistic regression was used 
to control for variables shown to be significant in the univariate analysis, and not in the 
causal pathway. The conditional logistic regression is similar to CMH Chi-square, in that 
it stratifies on the matched sets using the conditional maximum likelihood estimation 
(Fidler & Nagelkerke 2013:e58327). The advantage of using conditional logistic 
regression over the McNemar test or the CMH Chi-square test, is that covariates can be 
included in the model that are not in the list of the matching variables. 
 
3.2.5.3 Testing for mediation 
 
Mediation is a hypothesised causal chain in which one variable affects a second 
variable that, in turn, affects a third variable (Anon [s.a.]). It was hypothesised in this 
study that the effect of non-disclosure on MTCT is mediated by male partner 
involvement.  To determine mediation, presence of four conditions were assessed 
(figure 3.2) by performing three separate regression analyses (Kenny 2014): 
 
• The independent variable (non-disclosure) is significantly related to the 
dependent variable (MTCT) (path c). 
• The independent variable is significantly related to the Mediator variable (male 
partner involvement) (path a). 
• The mediator variable is significantly related to the dependent variable (path b). 
• When controlling for the effects of the mediator variable on the dependent 
variable, the effect of the IV on the DV (path c) is no longer significant (path c’). 
 
The significance of the mediation was tested using the Sobel test (Preacher 2010). 
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Figure 3.2:  Framework for mediation analysis 
 
3.2.5.4 Statistical software 
 
Statistical analysis was performed using the Statistical Package for Social Sciences 
(SPSS) version 22.0 for Windows. 
 
3.2.6 Ethical considerations 
 
Ethical considerations refer to the protection of the rights of all those involved or 
affected by the research study. To protect the rights of respondents, the three ethical 
principles of autonomy, beneficence/non-maleficence, and justice were upheld. The 
right to self-determination and full disclosure was ensured. The researcher ensured the 
respondents’ right to fair treatment and privacy. 
 
To protect the institution, ethical clearance was granted by the Research and Ethics 
Committee, Department of Health Studies, UNISA on 29 October 2013 (see annexure 
1) and local ethical approval wasobtained from Moi University, College of Health 
Sciences Research and Ethics Committee on 3 March 2014 (see annexure 2). 
Permission to conduct the study in Siaya County was sought and granted by the County 
Director of Health (see annexure 3 and annexure 4). All facilities received a copy of the 
research proposal and copies of the ethical clearance certificates together with the 
request for permission to conduct the study at the institution Additional verbal 
permission was obtained from the In-charges of the various health facilities.  
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3.2.6.1 Ethical considerations in data collection 
 
Any study involving human respondents is bound by certain ethical principles when it 
comes to data collection. Considerations of these principles is necessary, among the 
significant issues considered were voluntary participation, confidentiality and data 
protection. Voluntary participation is operationalised by obtaining of an informed 
consent from the respondents (see annexure 5), which involves the respondent knowing 
the purpose and nature of the study, the nature of his or her participation, and the 
potential risks and benefits involved. Implicit in this definition, however, is the belief that 
potential respondents will understand the information they are given. In this study, all 
these aspects were considered. The exact nature of the study was explained in a 
manner and language understandable to the respondent. Additional time was given to 
consider the information provided before making a decision to participate. To avoid 
undue influence, the respondents were not given any incentive to participate in the 
study. 
 
Personal information collected by researchers may be damaging to respondents if 
disclosed to a third party, especially with HIV/AIDS. Stigmatisation, discrimination, and 
other social or physical harms may occur if they are identified as different in some way 
from a larger community. The researcher ensured that information was collected in a 
confidential manner by identifying a room within the health facility where the 
questionnaire was filled. No identifier information was collected, and all information 
collected was entered into a database which was password protected. 
 
3.2.6.2 Ethical considerations in sampling 
 
In this study, steps were taken in ensuring that the respondents selected from the 
population were done in such a way that they accurately portray characteristics of the 
population. Health facilities sampled were the sub-County referral hospitals, which 
attend to HIV positive women from every corner of the sub-County. The respondents 
were further selected on a random basis, with selection being done on different days 
over a whole month to ensure representation of the population. Further, the effect of 
refusal to participate in the study was analysed to determine whether those who refused 
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to take part, differed significantly from those who participated. It was determined they 
had not differed significantly. 
 
Sample size estimation is a key component of empirical research as the sample size 
influences the quality and accuracy of the research. In general, increased sample size is 
associated with decreased sampling error.  Accordingly, researchers should focus on 
determining the smallest necessary sample size. This, as shown in section 3.2.3.4, was 
undertaken to arrive at the minimum required sample size. 
 
3.3 SCOPE OF THE STUDY 
 
The study focussed on determining whether non-disclosure of a positive HIV status to a 
male partner can have an impact on 6 week MTCT rates. The accessible population 
included HIV positive mothers and their babies who were born after January 2013, and 
had their 6 week PCR status determined.  
 
3.4 CONCLUSION 
 
The purpose of this chapter was to describe the research methodology of this study, 
explain the sample selection, describe the procedure used in designing the instrument 
and collecting the data, and provide an explanation of the statistical procedures used to 
analyse the data. 
 
Chapter 4 will present the results derived from the study. 
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CHAPTER 4 
 
ANALYSIS, PRESENTATION AND INTERPRETATION OF THE 
RESEARCH FINDINGS 
 
 
4.1 INTRODUCTION 
 
As mentioned in section 1.4, the purpose of this study was to determine whether an 
association exists between non-disclosure of a positive HIV status to partner and 
MTCT. Consequent to an association being found, the study further purposed to 
determine whether the effect of non-disclosure on MTCT is mediated by male partner 
involvement. The final objective was then to make recommendations for disclosure and 
male partner involvement as part of PMTCT. 
 
In order to realise these objective, a 1:4 matched case-control study design was 
implemented with relevant data being collected using a questionnaire developed 
purposefully for this study. SPSS statistical software version 22 was used to analyse the 
data collected. These details were presented in the previous chapter. 
 
This chapter reports and describes the results of the response rate, distribution of data, 
sample characteristics, and the association between non-disclosure and MTCT. Tables 
and diagrams have been used to facilitate a simplistic reader-friendly writing. Finally, a 
summary to the chapter is provided. 
 
4.2 DATA MANAGEMENT AND ANALYSIS 
 
4.2.1 Data management 
 
Data collection resulted in accumulation of data, primarily quantitative. An electronic 
database was created in excel 2013, following which the data was cleaned and edited 
to minimise data errors. The dataset was then exported to SPSS version 22. 
Examination of ranges and distributions of the variables was done to ensure all the 
values of all variables in the dataset are legitimate. Exploration of missing data revealed 
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no missing data. An analysis of the response rate and distribution of data are described 
below. 
 
4.2.1.1 Analysis of non-response bias 
 
Non-response is an important potential source of bias in a study as it could affect the 
magnitude and direction of measures of association (Barclay 2002:105; Curtis & 
Drennan 2013:188).  When only a subset of respondents provides follow-up information 
on exposures and outcomes, the participating subset may not be representative of the 
original sample. Owing to this importance, non-response bias analysis was performed 
first by examining the response rates among respondents and non-respondents. To test 
the null hypothesis that there was no difference between estimates for respondents and 
non-respondents, three variables (mother’s age, child birth weight, and disclosure 
status) were compared using a two-tailed, two-sample t-tests for continuous variables 
and chi-square for categorical variable.  
 
4.2.1.2 Assessing for normality of data 
 
When analysing differences between groups using parametric tests, a common 
assumption is that the dependent variable is approximately normally distributed for each 
group of the independent variable. When this assumption does not hold, it is impossible 
to draw accurate and reliable conclusions about reality (Ghasemi & Zahediasl 
2012:486). In order to determine the applicability of parametric tests in this study, 
continuous data was assessed for normality using Shapiro-Wilk’s test, and to ensure no 
outliers were present, an inspection of the box-plot was performed. 
 
4.2.3 Descriptive analysis 
 
The purpose of conducting a descriptive analysis is to characterise the respondents to 
better understand the composition of the sample. The characteristics of the sample 
population can be described using measures of central tendencies and dispersion. 
Central tendency gets at the typical score on the variable, while dispersion gets at how 
much variety there is in the scores. In this study, normally distributed data was 
represented by means and standard deviation while skewed data was presented using 
  
46 
mean and interquartile range as a measure of central tendency and dispersion 
respectively. 
 
4.2.4 Inferential statistics 
 
Univariate analysis was performed to identify differences between the case and the 
control groups using paired student’s t-test (continuous data) or the chi-square test 
(categorical variables) as appropriate (Gerstman 2008:204).  Mantel-Haenszel summary 
odds ratio and 95% confidence intervals for the odds ratio for the matched-pair data 
was calculated and Cochran-Mantel-Haenszel chi-square test was used to test for its 
significance (Tripepi, Jager, Dekker & Zoccali 2010:c318). Conditional logistic 
regression was then used to control for variables shown to be significant in the 
univariate analysis (Langholz & Goldstein 2001:67). 
 
4.3 SAMPLE CHARACTERISTICS 
 
4.3.1 Response rate 
 
Out of the 50 potential cases and 200 potential controls identified through a desk review 
of the HIV exposed infants register of the six sub-County referral hospitals in the 
County, 36 and 144 respectively were included in the analysis. The overall response 
rate was 72%. The numbers of cases and controls initially identified, reasons for 
exclusion, and numbers included in the analyses are shown in figure 4.1.  
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Figure 4.1: Number of potential cases and controls identified,  
excluded, and included in study 
 
The comparison of the mean mother’s age and child’s birth weight and disclosure status 
showed no statistical differences between respondents and non-respondents (table 
4.1).  
 
Table 4.1: Differences in characteristics of respondents vs. non-respondents  
 
Variable Respondents, n=180 Non-respondents, n=70 P value N (%) Mean (SD) N (%) Mean (SD) 
Mother’s age 
(years)  - 27.4 (5.4) - 26.9 (4.2) 0.327 
Child’s birth 
weight (kg) - 3.2 (0.6) - 2.9 (1.3) 0.289 
Disclosure 
status* (yes) 150 (83) - 55 (78) - 0.642 
 
* Disclosure status for non-respondents was obtained from medical records at the facility 
 
50 cases identified 200 controls 
14 excluded 
• 5 relocated to other 
countries 
• 3 died 
• 6 aged >6 months 
56 excluded 
• 10 relocated to 
other countries 
• 34 aged >18 
months old 
• 8 no 6 week PCR 
result in file 
• 4 double selected 
36 cases included in 
analysis 
144 controls 
included in analysis 
36 cased had 4 
controls each 
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The response rate of 72% reported in this study was deemed adequate (Curtis & 
Drennan 2013:188; Baruch 1999:421; Choung, Locke, Schleck, Ziegenfuss, Beebe, 
Zinsmeister & Talley 2013:93) especially as the minimum sample size required to give 
the study a power of 0.80 was achieved. Important too was the fact that the case and 
control groups did not significantly differ with regard to sample variables assessed. 
Therefore the researcher was confident of minimal errors in the estimations of exposure 
and association measures (Bjertness, Sagatun, Green, Lien, Søgaard & Selmer 
2010:602). 
 
4.3.2 Socio-demographic characteristics 
 
This section describes the socio-demographic characteristics of the respondents who 
took part in this study. Information on age, gender and birth weight of the infant was 
collected. Information of the age, marital status, number of siblings, and educational 
level was collected from the mother. 
 
4.3.2.1 Infant characteristics 
 
4.3.2.1.1 Child age 
 
The child age was normally distributed for both cases and controls as assessed by 
Shapiro-Wilk’s test (p>0.05). However, the distribution histogram of the case group 
reveals a bi-modal age distribution (figure 4.2). There were no outliers in the data, as 
assessed by inspection of the box-plot (figure 4.3). The overall median (min, max) age 
was 10 (1, 18) months. The Wilcoxon signed-rank test (Curtis & Drennan 2013:369) 
determined that there was no significant difference between the case and control 
median ages (10.5 (1, 18) vs. 9.5 (1, 18); P=0.703). 
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Figure 4.2: Age distribution for cases and controls 
 
 
 
Figure 4.3: Box-plot of cases and controls 
 
4.3.2.1.2 Child birth weight 
 
The birth weight of the babies were approximately normally distributed for cases and 
controls as assessed by Shapiro-Wilk’s test (p>0.05). There were several outliers in the 
control data, as assessed by inspection of the box-plot (figure 4.4). The overall mean 
(SD) birth weight was 3.2 (0.6) kg. The differences in mean birth weight between cases 
and controls However was statistically significant, with controls having a higher mean 
birth weight, M=0.35 (95% CI, 0.13 to 0.56), t (178)=3.163, p=.002. Birth weight was 
controlled for in the multi-variate analysis. 
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Figure 4.4:  Box-plot distribution of cases and controls 
 
4.3.2.1.2 Sex 
 
Overall, 43% (n=43) of the respondents were female, with no significant difference 
between males and females in the two groups (cases: 61% vs. 39%; p=0.467; controls: 
56% vs. 44%; p=0.341). 
 
4.3.2.2 Maternal characteristics 
 
4.3.2.2.1 Mother’s age 
 
The data on the maternal age approximated a normal distribution as assessed by 
Shapiro-Wilk’s test (p>0.05). There were no outliers as shown in the box-plot (figure 
4.5). The mean (SD) maternal age for the entire sample was 27.4 (5.4), with no 
significant difference in mean maternal age between cases and controls, M=1.5 (95% 
CI, -0.4 to 3.5), t (178)=0.041, p=0.139). 
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Figure 4.5: Box-plot distribution of cases and controls on mother’s age 
 
4.3.2.2.2 Mother’s marital status 
 
Most (n=119, 66.0%) of the mothers were married in a monogamous relationship, with a 
significant proportion (n=29, 16.0%) being in a polygamous relationship. The 
proportions did not significantly differ between cases and controls (p=0.447) as shown 
in table 4.2 in section 4.4. 
 
4.3.2.2.3 Mother’s educational level 
 
The majority of the respondents (n=141, 78.3%) has basic level of education, with only 
21.6% (n=39) having obtained post-primary education. The proportions did not 
significantly differ between cases and controls (p=0.640) (table 4.2). 
 
4.3.2.2.4 Number of children 
 
A visual analysis of the box plot (figure 4.6) shows there were several outliers with the 
histograms showing a positive skew for both cases and controls, with a skewness of 
1.56 (0.20) and 1.45 (0.39) respectively. The overall median (min, max) number of 
children was 3 (1-12), which did not significantly differ across the two groups: 2 (1-8) vs. 
3 (1-12); p=0.447. 
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Figure 4.6: Distribution of number of children for cases and controls 
 
 
 
Figure 4.7: Box-plot distribution of cases and controls 
 
4.3.2.2.5 Relationship duration 
 
The duration of a relationship with a partner had a right tail skew, with a Shapiro-Wilk’s 
test of p<0.001. An analysis of the box-plots (figure 4.8) shows there were no outliers 
for both cases and controls. The median relationship duration for both cases and 
controls was 1 year.  
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Figure 4.8:  Box-plot of duration of relationship 
 
4.3.2.2.6 Duration aware of status 
 
The duration of time aware of one’s status had a right tail skew, but no outliers (figure 
4.9). Shapiro-Wilk testing the null hypothesis that your data's distribution is equal to a 
normal distribution was <0.001. The overall median (min, max) time aware of one’s 
status was 16 months (1-24), which did not significantly differ across the two groups: 17 
(1-20) vs. 19 (3-24); P=0.627. 
 
 
Figure 4.9:  Box-plot of duration aware of status 
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4.4 BIVARIATE ANALYSIS OF OUTCOME AND PREDICTOR VARIABLES 
 
4.4.1 Non-disclosure and MTCT  
 
Overall, the non-disclosure rate to a partner was 16.7% (n=30). Among cases, mothers 
who had not disclosed to their partners was 52.8% (n=19) as opposed to 7.6% (n=11) 
among controls, with an odd ratio of 13.5 (95% CI 5.5-33.2), p<0.001 (table 4.2). 
 
Table 4.2: Bivariate analysis of non-disclosure of positive HIV status among 
cases and controls 
 
Variable 
Overall 
N (%) 
Outcome at 6 
weeks Odd ratio 
(CI) P value 
MH OR 
(CI)* P value Cases, 
n (%) 
Controls, 
n (%) 
Non-
dis-
closure 
Yes 30 
(16.7) 
19 
(52.8) 
11  
(7.6) 13.5  
(5.5-33.2) <0.001 
10.1  
(4.0-26.0) <0.0001 No 150 
(83.3) 
17 
(47.2) 133 (92.4) 
 
*Mantel Haenszel odds ratio, matching on health facility 
 
4.4.2 Other predictors and MTCT 
 
Two other variables were significantly associated with HIV status at 6 weeks: Infant 
prophylaxis and absolute breast feeding in the first 6 months were protective of MTCT 
OR=0.12 (0-0.9), p=0.005 and 0.19 (0.07-0.48), p=0.001 respectively. An awareness of 
partner status and male partner involvement were similarly found to be significantly 
associated with MTCT, OR=0.30 (0.1-0.5), p=0.001 and OR=0.12 (0.1-0.90), p=0.001 
(table 4.3).  
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Table 4.3:  Univariate analysis of outcome and clinical predictor variables 
 
Variable Total,  n (%) 
Case,  
n (%) 
Control, 
n (%) OR (95% CI) P value 
Infant 
prophylaxis 
Yes 174 (96.7) 34 (89.5) 140 (98.6) 
0.12 (0-0.9) 0.005** 
No 6 (3.3) 4 (10.5) 2 (1.4) 
Place of birth 
Health facility 150 (83.3) 30 (78.9) 120 (84.5) 
0.6 (0.3-1.6) 0.350 
Home  8 (21.2) 22 (15.5) 
Type of feeding 
Breastfeeding 158 (87.8) 26 (68.4) 132 (93.0) 
0.19 (0.07-0.48) 0.001** 
Mixed feeding 22 (12.2) 12 (31.6) 10 (7.0) 
Mode of 
delivery a 
No procedure 172 (95.6) 38 (100) 134 (94.4) 
- - 
procedure 8 (4.4) 0 (0) 8 (5.6) 
Antenatal clinic 
attendance a 
Yes 179 (99.4) 38 (100) 141 (99.3) 
- - 
No 1 (0.6) 0 (0) 1 (0.7) 
Partner 
involvement 
Yes 33 (18.3) 4 (10.5) 29 (20.4) 
0.12 (0.1-0.90) 0.001** 
No 34 (89.5) 34 (89.5) 113 (79.6) 
Maternal 
prophylaxis 
Yes 165 (91.7) 32 (84.2) 133 (93.7) 
0.39 (0.13-1.19) 0.097 
No 15 (8.3) 6 (15.8) 9 (6.3) 
Duration aware 
of status 
<1 year 55 (30.6) 9 (23.7) 46 (32.4) 
0.7 (0.3-1.7) 0.425 
>1 year 125 (69.4) 29 (76.3) 96 (67.6) 
Duration of 
relationship with 
partner 
<1 year 155 (86.6) 31 (83.8) 124 (87.3) 
0.8 (0.2-2.3) 0.713 
>1 year 24 (13.4) 6 (16.2) 18 (12.7) 
Time of 
disclosure 
Before 
pregnancy 143 (93.5) 18 (85.7) 125 (94.7) 
0.2 (0.1-1.4) 0.112 
After 
pregnancy 
10 (6.5) 3 (14.3) 7 (5.3) 
Time to 
disclosure 
<3 months 116 (75.8) 17 (85) 99 (77.4) 
1 (0.2-4.0) 1.000 
>3 months 37 (24.2) 3 (15) 34 (25.6) 
Awareness of 
partner status 
Yes 109 (60.6) 14 (36.8) 95 (66.9) 
0.3 (0.1-0.5) 0.001** 
No 71 (39.4) 24 (63.2) 47 (33.1) 
Tested as a 
couple 
Yes 43 (23.9) 6 (15.8) 37 (26.1) 
0.56 (0.23-1.36) 0.201 
No 137 (76.1) 32 (84.2) 105 (73.9) 
Disclosed to 
other people 
Yes 135 (75.0) 27 (71.1) 108 (76.1) 
0.8 (0.3-1.7) 0.528 
No 45 (25) 11 (28.9) 34 (23.9) 
Encouraged to 
disclose by 
health worker 
Yes 167 (92.8) 36 (94.7) 131 (92.3) 
1.7 (0.3-8.0) 0.494 
No 13 (7.2) 2 (5.3) 11 (7.7) 
Follow-up on 
disclosure 
Yes 160 (88.9) 33 (86.8) 127 (89.4) 
0.9 (0.2-2.7) 0.809 
No 20 (11.1) 5 (13.2) 15 (10.6) 
** Significant at p=0.05 
 
4.4.3 Multivariate analysis 
 
At multivariate analysis, using conditional logistic regression, non-disclosure of a 
positive HIV status to a partner remained a significant risk factor for MTCT of HIV, aOR 
8.9 (95% CI 3.0-26.3) after controlling for infant age and awareness of partner status 
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(table 4.4), which was the only predictor variable not in the causal pathway that was 
statistically associated with the outcome variable. 
 
Table 4.4: Adjusted OR for non-disclosure according to multiple logistic re-
gression analysis 
 
Variable Unadjusted OR (CI) Adjusted OR (CI) P value 
Non-disclosure of 
positive HIV status 10.1 (4.0-26.0) 8.9 (3.0-26.3) <0.0001 
 
(Variables included in the analysis were infant age and awareness of partner status) 
 
4.4.4 Testing for mediation 
 
The regression coefficient for the analysis of path c shows that non-disclosure was 
significantly related to MTCT (path c) (0.37, p<0.001), satisfying the first condition for 
mediation. Similarly, the regression coefficients for the relationship between non-
disclosure and male partner involvement (path a) and between male partner 
involvement and MTCT (path b) were significantly related, 0.51, p<0.001 and 0.36, 
p<0.001, satisfying the second and third conditions for mediation respectively. The 
standardised indirect effect (path c) was substantially reduced [(0.47) (0.36)=0.17 
p=0.01] compared to the direct effect coefficient of 0.37. This last condition supports 
male partner involvement partially mediating the relationship between non-disclosure 
and MTCT (figure 4.10). 
 
. 
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Figure 4.10: Standardised regression coefficients for relationship between non-
disclosure and HIV status at 6 weeks as mediated by male partner involvement  
(Standard regression coefficient between non-disclosure and outcome controlling for male 
partner involvement in parenthesis) 
Note: *p<0.001; **p<0.01 
 
4.5 OVERVIEW OF RESEARCH FINDINGS 
 
In this study, the overall prevalence of non-disclosure was 16.7%, with non-disclosure 
being more common among cases (52.8%) as compared to controls (controls 7.6%), 
resulting in an odds ratio of 13.5 (5.5-33.2). 
 
In the univariate analysis, Infant prophylaxis and absolute breast feeding in the first 6 
months were protective of MTCT OR=0.12 (0-0.9), p=0.005 and 0.19 (0.07-0.48), 
p=0.001 respectively. Awareness of partner status and male partner involvement were 
similarly found to be significantly associated with MTCT, OR=0.30 (0.1-0.5), p=0.001 
and OR=0.12 (0.1-0.90), p=0.001. 
 
In multi-variate analysis, the effect of non-disclosure on MTCT maintained significance 
after controlling for potential confounders (aOR 8.9 (3.0-26.3); p<0.0001).  
Male partner  
involvement 
Non- 
disclosure 
Infant HIV 
Status at 6 
0.51*  0.36* 
0.37* 
(0.17**) 
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A mediation analysis demonstrated that the effect of non-disclosure on MTCT is partially 
mediated by male partner involvement (0.17, p=0.01). 
 
4.6 CONCLUSION 
 
This chapter discussed procedures employed in the data analysis, and the research 
findings. The analysis was performed with the help of SPSS version 22.0 statistical 
software package. Data analysed and presented in this chapter included response rate 
analysis, demographic characteristics. Findings on bivariate correlation, multiple 
regression and mediation results were also discussed. Graphs, charts, scatter plots and 
frequency tables were used along with text description to present and analyse the 
findings. Chapter 5 will present a summary and interpretation of the findings, while 
discussing the implications of the findings.   
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CHAPTER 5 
 
CONCLUSIONS AND RECOMMENDATIONS 
 
 
5.1 INTRODUCTION 
 
The purpose of the study to determine whether an association exists between non-
disclosure of HIV positive status and MTCT was addressed during the course of this 
dissertation.  An association between non-disclosure and MTCT was established and 
enough evidence provided on the mediation effect of male partner involvement on the 
association. A summary of the findings and its interpretation is presented below. This 
chapter additionally draws out the implications of the findings while cognisance is given 
to the limitations of the study design. Recommendations for disclosure and male partner 
involvement, as part of PMTCT are then presented.  
 
5.2 RESEARCH DESIGN AND METHODS 
 
A matched case-control study was conducted among HIV positive women and their 
infants receiving HIV care and treatment at six referral hospitals in Siaya County. Cases 
were defined as infants who were HIV positive at 6 week of age and controls as infants 
who were HIV negative. For every case identified by reviews of HIV cohort registers, 
four controls from the same facilities were also included by random sampling of HIV 
exposed infants with a negative status. Mothers who accepted to be respondents were 
invited to complete a questionnaire which collected data on disclosure status among 
other variables. Data collected were entered on an Excel spread sheet for data cleaning 
and subsequently transferred to SPSS for analysis. 
 
5.3 SUMMARY AND INTERPRETATION OF THE RESEARCH FINDINGS 
 
Two important findings have stemmed out of this research effort. Primary is that HIV 
exposed infants whose mothers have not disclosed their positive HIV status to their 
partners are at a higher risk of HIV acquisition as compared to those who have 
  
60 
disclosed. Secondary is the finding that male partner involvement is a mediator variable 
in the effect of non-disclosure on MTCT. 
 
The study has also demonstrated infant prophylaxis, absolute breast feeding in the first 
6 months, awareness of partner status and male partner involvement to be protective 
against MTCT.  
 
In the current study, more than two thirds (83.3%) of HIV positive women reported 
having disclosed their HIV status to their partner. This proportion is similar to those 
reported in most studies in sub-Sahara, with disclosure proportions ranging from 16.7% 
to 86% (Medley et al 2004:300). In a study on 3538 HIV positive patients in Kenya, 
Tanzania, and Botswana (Bachanas et al 2013:427), 80% reported disclosing their 
status to their partner. These findings were corroborated by a study of 20 HIV positive 
pregnant women in Kenya (Walcott, Hatcher, Kwena & Turan 2013:1118), in which 70% 
had disclosed their status to their partner.  
 
The small proportion (16.7%) of non-disclosure in this current study could be an 
underestimate as disclosure was self-reported. As such, it is possible that some of the 
mothers who reported disclosing to their partner had not disclosed. But to minimise 
such reports, the researcher ensured that no single question in the questionnaire was 
given biased emphasis during data collection to ensure respondents did not feel some 
of the questions were more important hence requiring them to present themselves in 
good light. Additionally, the responses were corroborated with disclosure status 
reported in the patient’s file, and where discordance was found or when no response 
was recorded, the respondent was contacted to clarify the true position.  
 
The first significant finding not reported in any of the earlier studies is the higher 
proportion of non-disclosure among mothers of HIV positive infants as compared to HIV 
negative infants.  In this study, 52.8% of women with a HIV positive infant had not 
disclosed their status, compared to only 7.6% among those who had a HIV negative 
infant, representing an odds ratio of 13.5 (95% CI 5.5-33.2). The association maintained 
significance even after controlling for infant age and awareness of partner status, which 
were significantly associated with MTCT. Despite also being significantly associated 
with the outcome, infant prophylaxis, type of feeding in the first 6 months, and male 
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partner involvement were not controlled as they were deemed to be in the causal 
pathway. 
 
Several explanations have been put forth as to why a pregnant woman may be unwilling 
to disclose her HIV status to her partner. For the woman, disclosure of her HIV infection 
has far-reaching personal implications. As pointed out by several studies, pregnant 
women must overcome a number of difficulties when disclosing their HIV status to their 
partner, including but not limited to the fear of abandonment, discrimination, violence, 
accusations of infidelity and fear of a loss of economic support from the partner 
(Farquhar et al 2004:1624; Maman & Medley 2011:377). The fears experienced are 
valid as exemplified by Farquhar et al (2004:1625) where women who work outside the 
home or have more sexual experience believe that they are more likely to be blamed for 
infidelity and do not disclose as a result of this fear, and a lower socioeconomic status is 
related to an increased likelihood of disclosure to a partner. Past experiences of 
violence also decreased the likelihood that women would disclose their HIV status to 
their partners (Medley et al 2004:300). Disclosure is also impacted by issues that relate 
to the couple's relationship; married women and those who have discussed HIV testing 
prior to the test are more likely to disclose their diagnosis to their partner (Makin, 
Forsyth, Visser, Sikkema, Neufeld & Jeffery 2008:913). 
 
Therefore it comes as no surprise that some women choose to remain silent about their 
HIV infection. The secrecy as demonstrated in this research may increase the risk of 
MTCT, and the mechanism as explained in several studies include delays in starting 
ART, poor compliance, lack of post-natal infant prophylaxis or breastfeeding (Aluisio et 
al 2011:79; Bachanas et al 2013:428) through lack of partner support as shown in this 
current study. 
 
The second significant finding was the partial mediation of the effect of non-disclosure 
on MTCT by male partner involvement. Findings in this current research demonstrate 
that mothers with HIV positive infants have a higher rate of male partner non-
involvement (10.5%) compared to 20% among those with HIV negative infants. The 
mediation analysis earlier presented suggests a possibility of an association between 
non-disclosure and MTCT being partly mediated by male partner involvement usually 
through poor compliance with PMTCT interventions (Kalembo et al 2013:40). These 
include poor attendance to antenatal clinics, non-adherence to maternal and infant 
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ARVs, non-adherence to infant feeding method selected, and loss to follow up among 
HIV exposed infants (Aluisio et al 2011:78; Bii, Otieno-Nyunya, Siika & Rotich 2008:158; 
Jasseron et al 2013:431; Laher et al 2012:94; Msuya et al 2008:706; Nyondo, 
Chimwaza & Muula 2014:36; Roxby et al 2013:34; Varga et al 2006:955). The overall 
low rates of male partner involvement (18.3%) are similar to low rates found in Uganda 
(Byamugisha et al 2010:54) reflecting a need for focussing on male partner 
involvement. 
 
5.4 CONCLUSIONS 
 
The non-disclosure rates of HIV positive status in this study were high. However, 
mothers with HIV positive infants were significantly more likely not to have disclosed 
their HIV positive status to their partner as compared to those with a HIV negative 
infant. The non-disclosure of a HIV positive status was found to be significantly 
associated with MTCT, even after controlling for infant age and awareness of partner 
status which was the only variable significantly associated with MTCT and was not in 
the proposed causal pathway. The effect of non-disclosure on MTCT was found to be 
partially mediated by male partner involvement. 
 
5.5 RECOMMENDATIONS 
 
5.5.1 Recommendations for disclosure 
 
Individuals are motivated by a multiplicity of factors in their decisions regarding 
disclosure of their HIV status, and thus multiple strategies are warranted to promote 
safe disclosure to a partner. In sub-Saharan Africa PMTCT guidelines encourage self-
disclosure of HIV status, being keener on ensuring confidentiality and privacy. While this 
is key, placing the burden of disclosure on the women has not yielded high enough 
disclosure rates in many settings. Recognising the complexities involving disclosure for 
the women, and the potential negative outcomes following disclosure, strategies to 
enhance disclosure must be carefully designed to address the fears. One of the most 
critical is removing the burden of disclosure from the women. 
 
Facilitated HIV disclosure is one such strategy whereby a counsellor is present during 
the disclosure period to help with understanding and information. This approach has 
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been shown to receive favour among HIV infected couples as it facilitates disclosure 
while reducing potential for adverse events (Walcott et al 2013:1116). On the other 
hand, the approach does not entirely negate potential adverse events that may occur 
later on after the counsellor has left the couples. 
 
Another strategy that can be adopted is testing for HIV together as a couple. The 
strategy not only removes the burden of disclosure on any one individual, but also 
provides a safe environment for disclosure to occur. Another potential benefit of couples 
testing is in the partner support offered to access and adhere to ART and interventions 
to prevent mother-to-child transmission of HIV. 
 
Home-based couple HIV counselling and testing with support for mutual disclosure can 
also be an effective and acceptable method (Walcott et al 2013:1120). However, the 
strategy can also be predisposed to stigma for the couple and erroneous disclosure to 
other family members resulting in breach of confidentiality by the health worker. 
 
Importantly, it is worth considering that some of the barriers to disclosure hinge on 
gender and societal norms whereby in some cultures women are not allowed to have a 
voice.  Women's empowerment programmes can shift gender norms and ultimately 
facilitate HIV status disclosure to sexual partners. Addressing stigma associated with 
HIV status through community-based programmes is another way of changing societal 
norms. The development of support groups for infected women provides another 
avenue for ongoing support that may help women work through their disclosure 
processes. 
 
5.5.2 Recommendations for male partner involvement 
 
Strengthening male partner involvement not only reduces MTCT through enhanced 
adherence, but also presents an avenue for safe disclosure of HIV status.  It creates an 
opportunity for individual men and couple HIV testing, actions that remove the 
disclosure burden from the woman (Jasseron et al 2013:495). Theuring, Mbezi, 
Luvanda, Jordan-Harder, Kunz and Harms (2009:96) showed that men actually support 
and are not averse to being involved in PMTCT and antenatal-clinic services, despite 
barriers of lack of knowledge, health services representing a female responsibility, and 
fear of HIV test results. Moreover, the traditional gender roles that empower men to 
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make decisions regarding their female partners’ medical care enable them to determine 
the success of PMTCT programmes.  
 
A successful intervention aimed at improving male involvement ought to address these 
barriers. Experiences from programmes working with men on HIV/AIDS-related issues 
in various African countries attest to the importance of constructively engaging men to 
address women’s uptake of PMTCT interventions (Kalembo et al 2013:40). The first 
step involves appealing to men to share equal responsibility and participate in joint 
decision-making with their partners, without necessarily controlling those decisions. 
Health facilities can facilitate this role by offering services that are welcoming to male 
clientele with an addition of initiatives that are exclusively for men. Other areas have 
reported increased male involvement through the use of invitation letters to the male 
partners to attend either PMTCT or ANC services (Byamugisha et al 2010:54). 
 
Behaviour change and communication through the media may be used to increase the 
number of men accompanying their female partners to antenatal clinics by changing the 
gender stereotype and providing more information. One additional strategy that can be 
used is peer-peer sensitisation of men. This may involve recruiting leaders from the 
men’s support groups to serve as peer discussion leaders to deliver educational 
sessions to other men in their communities about the importance of men’s support and 
engagement in PMTCT programmes. 
 
5.5.3 Recommendations for future research 
 
From previous publications and this current study, several potential areas of future 
research have been identified. First, although this study established a significant 
association between MTCT and three behavioural predictor variables (non-disclosure, 
awareness of partner status, and male partner involvement), more studies need to be 
undertaken to comprehensively study other behavioural factors not addressed in the 
current study. Moreover, while mediation on the effect between MTCT and non-
disclosure by male partner involvement was established, it is imprudent not to realise 
that the model thus tested is very simplistic. More detailed mediation models should be 
explicated to comprehensively understand the mediation mechanism of the effect of 
non-disclosure on MTCT. 
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As a follow up to this study, it would be interesting to replicate the study in a 
metropolitan area or in a culture where the health seeking behaviour of women and 
children is not solely determined by men.  
 
5.6 CONTRIBUTIONS OF THE STUDY 
 
This study has provided useful insights in the fight against MTCT of HIV. It has 
supported findings from other studies of a high rate of disclosure among HIV positive 
pregnant women. The study has also demonstrated that HIV positive women with a HIV 
positive child are likely not to have disclosed their status to their partner. Infant 
prophylaxis and mode of feeding in the first six month has been shown to be still 
important determinants of MTCT of HIV in the era of universal access to HIV medicines. 
Additionally, evidence has been provided that awareness of male partner involvement is 
significant determinants of MTCT of HIV. 
 
Finally, in addition to proposing ways of improving disclosure among HIV positive 
pregnant women, the study has also demonstrated how to apply a matched case-
control design to assess relationships between two variables. 
 
5.7 LIMITATION OF THE STUDY 
 
Despite an important contribution to our existing knowledge about non-disclosure and 
MTCT, care must be taken in generalising this study’s findings. Inasmuch as the study 
involved all referral facilities in the County, the findings may not be generalised to other 
settings with varying socio-demographic, cultural and economic characteristics.   
 
Another possible limitation is the possibility of social desirability bias owing to the nature 
of data collection. Self-reports usually have risk of introducing bias as respondents may 
lie about themselves to present themselves in good light. This study minimised that 
possibility by corroborating the reported findings as much as possible with patients’ 
records, and assuring the respondents of data anonymity, privacy and confidentiality. 
 
While every effort was made to ensure the sample of controls was representative of the 
general population, it is possible that this was not the case as the study was facility-
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based. Besides, pregnant mothers not attending ante natal clinics are likely to differ 
from those who seek care from health facilities. 
 
5.8 FINAL REMARKS 
 
Given the potential for PMTCT interventions to eliminate MTCT, and the evidence 
emanating from this study suggesting an important association among non-disclosure of 
HIV positive status, male partner involvement and infant HIV acquisition, which hitherto 
was unclear, a re-examination of policies on disclosure and male-partner involvement 
ought to occur in order to address these two behavioural predictors of infant HIV 
acquisition. While policy on HIV testing and counselling advocate on partner disclosure 
as part of post-test counselling, very little is done to ensure disclosure indeed happens. 
This evidence should invigorate efforts to integrate more effective methods that ensure 
disclosure occurs in a safe environment. Additionally, male partner involvement which 
serves the dual purpose of increasing awareness of HIV status and enhanced 
disclosure should be prioritised. 
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